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The increased white adipose tissue mass associated with obesity is the
result of both hyperplasia and hypertrophy of adipocytes. While adipocyte
development and transcriptional processes are well studied in vitro, regulation of
in vivo genes (such as leptin), the identity of the adipocyte progenitor cells and
the development of the adipose organ have not been defined in vivo.

In this thesis, firstly KLF4 was discovered to be an essential early
regulator

of

adipogenesis.

KLF4

together

with

Krox20

cooperatively

transactivates C/EBPβ, suggesting that KLF4 and Krox20 are part of an
immediate early transcriptional network.

This network is upregulated in a

lipodystrophic animal model, encoding a dominant negative transgene against
C/EBP factors, suggesting that these animals carry hyper-adipogenic residual fat
pads, which provide a niche for transplantation experiments for identifying
possible adipocyte progenitors. When injected into the residual fat pads of
lipodystrophic mouse, indeed, a cell population, sorted from stromavascular
fraction reconstitutes a functional white adipose tissue. Next, through a leptinluciferase animal model, where luciferase is expressed only in adipocytes (see
below), the location and timing of embryonic adipose development were

determined. Identification of the location and timing led the way to study gene
regulation and morphology of the developing adipose tissue in embryos.

Leptin is an in vivo regulated adipocyte hormone, which is the afferent
signal in a negative feedback loop controlling body weight and energy
expenditure. Leptin is secreted in proportion to adipose tissue mass. This
suggests the possibility that cellular lipid content is sensed and that a fuller
understanding of the mechanisms of leptin production could lead to the
delineation of a lipid sensing mechanism in fat cells and possibly other cell types.
To discover this mechanism, we searched for the region/s in the leptin gene
promoter that control the transcription of the leptin gene using a deletion series of
BAC transgenic mouse lines that express luciferase under the control of
overlapping leptin regulatory sequences. Cis elements that confer qualitative and
quantitative control of the leptin gene are located between – 762B and +8kb
relative to the transcription start site.
Since luciferase is driven by leptin regulatory sequences in leptinluciferase animals and leptin levels are highly correlated with the amount of body
fat, luciferase expression can be used as a surrogate for studying changes in the
amount of adipose tissue. To study the responses of adipocytes to changes in
weight, leptin-luciferase animals were used to show that weight loss induced by
fasting or leptin treatment results in the retention of lipid-depleted adipocytes in
adipose depots. This work led to the identification of a cellular program that
controls the recovery of adipose fat mass after weight loss.
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CHAPTER 1:
Introduction
Obesity as a Global Health Problem
The first law of thermodynamics basically states that a thermodynamic
system can store or hold energy and this energy is conserved. The regulation of
body weight also adheres this principle of thermodynamics. Body fat increases
when energy intake is consistently greater than energy expenditure and
decreases when energy intake is smaller than energy expenditure. Excess body
fat and obesity are the result of sustained positive energy balance. In the last 20
years, medical and public health interest in obesity has skyrocketed due to the
increased prevalence of obesity in United States. Today, the obesity epidemic
has spread from the US to Europe and is now emerging in middle and even low
income countries. In the United States, this trend affects all ages, races and
socio-economic groups (Kuczmarski et al., 1994b).
Obesity is associated with many other health complications including
diabetes mellitus, coronary heart disease, several forms of cancer, and sleepbreathing disorders (Kopelman, 2000a, b) (Friedman, 2000). Because of the
health and economic costs of obesity, the immediate need to understand why
humans are gaining weight has increased in recent years. The global epidemic of
obesity possibly results from a combination factors such as genetic factors,
increased availability of high-calorie foods and decreased requirement for
physical activity due to sedentary lifestyle in modern society. Obesity became so
1

common within the world's population that it is beginning to replace common
problems such as infectious diseases and under-nutrition as the most significant
contributor to ill health (Kopelman, 2000a).
Definition of obesity
Obesity is defined as excessive accumulation of body fat. Body fat is
most simply estimated by
using

a

combines
height.
Belgian

formula

that

weight

and

Invented

by

polymath,

a

body

mass index (BMI) is defined
as

the

weight

individual's
divided

by

body
the

square of his/her height,
Figure 1 BMI and classification of obesity (adapted
from W.H.O.)

producing a unit measure of
kg/m2 (Dalton et al., 2003).

The formula assumes that most variation in weight for people of the same height
is due to fat mass. The assumption, for example, does not hold true for people
with increased muscle size.
World Health Organization classifies individuals with BMI more than 25 as
overweight, more than 30 as obese and more than 40 as morbidly obese
respectively (Figure 1) (Committee, 1995; WHO, 1997). It is important to note
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that, owing to differences in body proportions, BMI may not correspond to the
exact same degree of fatness among different people as indicated above.
Despite the fact that it does not provide an accurate measure of percent body fat,
BMI allows meaningful comparisons of weight status within and between
populations and the identification of individuals at risk of morbidity and mortality.
For this reason, BMI sets up a general index and is very useful for
epidemiological studies.

Consistent with this, increased BMI has been found to

be associated with the incidence of type II diabetes, CHD and hypertension
(Willett et al., 1999).
One other accepted measure for obesity is waist circumference which
correlates with the risk for CHD such as hypertension or blood lipid levels
(Dalton et al., 2003). The National, Heart, Lung and Blood Institute classifies a
high risk of obesity if men have a waist circumference greater than 102 cm, and
women have a waist circumference greater than 88 cm (Colman et al., 1995;
Flegal, 2007). The choice of cut-off points on the waist circumference involves a
trade-off between sensitivity and specificity similar to that for BMI.
Obesity as an emerging health concern
Obesity is becoming a major health concern in the United States and an
increasing problem in the developing world. The most recent National Health and
Nutrition Examination Survey (NHANES) indicates that 66% of adults in the US
are either overweight or obese, (Ogden et al., 2006). Obese individuals made up
32.2% of the American adult population as of 2004, compared to 12.8% in 1962

3

(Kuczmarski et al., 1994a; Kuczmarski et al., 1994b). Interestingly, this
increasing trend manifests itself even more among children and adolescents. The
prevalence of overweight/obese children in the United States more than doubled
since 1970s (Troiano et al., 1995; Yanovski and Yanovski, 2002).
Obesity is not only a problem of United States, but a common condition in
almost every continent. In Europe, a very comprehensive study (MONICA)
showed that on average, 15% of men and 22% of women were obese. More than
half the adult population between 35 and 65 years of age in Europe were either
overweight or obese (Silventoinen et al., 2004).

Figure 2 Distribution of BMI in different age and sex categories (Adapted from Friedman,
2000)

Even though obesity is often viewed as a problem of rich and developed
countries due to food availability, it is actually rapidly increasing even in the
developing world (Taubes, 1998). In fact, it is estimated that the number of obese
4

people in the world is equivalent to those suffering from hunger. For instance, in
Turkey, the overall prevalence rate of overweight was 25.0% and of obesity was
19.4% as of 2003. The prevalence of overweight among women was 24.3% and
obesity 24.6%; 25.9% of men were overweight, and 14.4% were obese (Hatemi
et al., 2003). Incidence of obesity has also plummeted in countries such as
Japan, Korea, China, and Thailand , where being overweight has traditionally not
been a concern due to the traditional lifestyle and food habits (Popkin, 1994).
Obesity rates amongst Pacific Islanders are astonishingly high, with a prevalence
of over 60% in certain populations, which has developed a lot of interest for
researchers to identify possible genetic factors (Bonnen et al., 2006; Hodge et
al., 1995; Shmulewitz et al., 2001).
Obesity as a disorder is defined as a threshold. In this regard; small
changes in average weight might have a different effect on its incidence.
Incidence of obesity has increased from 23.3% to 30.9% in recent years (Figure
2). On the other hand, the average weight of a typical American increased only 7
to 10 pounds (Friedman, 2003). This suggests that a small increase in average
BMI of a population such as US population can lead to marked increase in the
number of obese individuals. It is thus important to consider obesity as a
threshold when interpreting the statistics for prevalence of obesity epidemic
(Friedman, 2003) (Figure 2).
Causes of Obesity
Recent evidence in clinical and basic research shed light on what could be
causing the obesity epidemic. As for other diseases, it is plausible to think that
5

obesity is determined by combination of factors, both environmental and genetic.
From a population genetics point of view, it is almost impossible that the genetic
make-up has changed in the last century, which suggests that environmental
alterations be the major determining factor. Consistent with this, obesity epidemic
is occurring predominantly among humans and house pets (Kopelman, 2000a;
Mason, 1970; Overgaauw and Kwant, 2008; Stuart, 2008). This observation itself
implies that the shift of environment is the major cause of the recent epidemic. As
will be discussed, one major theory suggests that increased food availability and
shift to sedentary life styles with the development of technology can explain the
increase in the incidence of obesity (Campbell, 2008; Levitan et al., 2006; Neel,
1999a).
Genetic factors are the major determinants of an individual’s reaction to
his/her environment. As much as 80% of variability in BMI can be attributed to
genetic factors (Stunkard et al., 1990). Furthermore, twin and adoption studies
suggest that body weight is among the most genetically controlled traits (Maes et
al., 1997). Correlation between monozygotic twins reared apart/together does not
differ significantly (Maes et al., 1997).

In parallel, people sharing the same

childhood do not necessarily show the same body weight. All these studies imply
that genetic influences on BMI/body weight are substantial. Next sections will
discuss the factors that affect obesity and possible evolutionary theories that
explain the obese gene selection.

6

Genetic contribution to Obesity
The fact that body weight in adults tend to stay stable suggests that body
weight is maintained by an inherent homeostatic circuit. When the food intake is
restricted to maintain a lesser body weight, energy expenditure decreases to
balance this alteration or when a person overfeeds himself/herself, energy
expenditure increases for the same reason (Cohn and Joseph, 1962). This, itself
suggests that body weight is regulated by inherent cues of the organism.
Studies in humans using both adoption and twins have shown that body
weight is highly heritable. A large study of more than 100.000 individuals found a
BMI correlation of 0.70 in monozygotic twins, with a heritability of %50-90 (Maes
et al., 1997). This heritability is comparable to traits regarded as highly heritable
such as height and even greater than traits which were accepted to have genetic
roots.

Furthermore, children can be predicted to be obese less than %10

chance if both parents have a normal body weight, %50 if one parent is obese
and 70% if both parents are obese (Stunkard et al., 1980a; Stunkard et al.,
1980b). In parallel, mouse studies show that genetically different mouse strains
gain different weights upon high fat feeding. For example, exposure to high fat
diet results weight gain but the degree of weight gain varies depending on the
strain background.

Among the mouse strains, C57B6/J and AKR/J become

obese on high fat diet, on the contrary to SWR/J and FVBN/J (Astrup et al., 1994;
Prpic et al., 2002; West et al., 1994).

7

In order to compromise with the environmental and genetic factors, many
researchers propose that susceptibility to obesity is under genetic control and
environment/behavior
determine

the

expressivity

phenotypic
of

the

susceptible genotype.
Rare Mendelian single
gene disorders also occur in

Figure 3: Depiction of thrifty gene hypothesis

obesity,

which

another

indication

presents
of

the

genetic basis of obesity. An
example of this type of abnormality is ob and db mutations. Recessive mutations
in the ob and db genes cause a syndrome of extreme obesity and diabetes
(Coleman, 1978). Mice having mutations at either of these loci weigh 2 to 3 times
more the wild type littermates. An early parabiosis experiment by Coleman and
colleagues found that ob/ob partners of db/db mice experienced rapid weight
loss, ate little food, became hypoglycemic, and died within 26 days of parabiosis
surgery (Coleman, 1978). Similar responses were reported for normal, lean mice
parabiosed to db/db mice, and it was concluded that both lean and ob/ob mice
had normal satiety centers that were responsive to a satiety factor produced by
db/db mice. The similarity of the obesity syndromes observed in the ob/ob and
db/db genotypes also led to the conclusion that the two different genes influenced
the same satiety mechanism. These observations led to the fact that ob/ob mice
8

had a normal satiety center but were unable to produce the humoral satiety
signal, whereas db/db mice produced the signal but had a defective satiety
center.

This factor was later identified by our lab in 1994, which will be

mentioned in the following sections of this thesis (Zhang et al., 1994).
An evolutionary perspective of obesity: Environment vs Genetics
Body weight is determined by environment and behavior. As discussed
above, body weight is kept in limits through homeostatic mechanisms. In this
regard, then comes the question why this balance mechanism did not work at
least for humans during the obesity epidemic. Relevant observations from recent
studies show that every other species on earth, fat metabolism is well regulated
and that most wild animals are in fact very lean and that they remain lean even
when adequate food is supplied unless there is an infectious disease causing
obesity (Dhurandhar, 2001). The thrifty gene hypothesis proposed by geneticist
James Neel gives an explanation to this fundamental problem (Figure 3) (Neel,
1962) (Neel, 1999a, b). Obesity is quite common, and it is evident that it likely
had a strong genetic basis. Neel proposed that obesity/diabetes genes
historically were advantageous in ancient times where food was scarce, but they
became detrimental in the modern world. These obesity genes, named as thrifty
genes by Neel, are genes which enable individuals to efficiently collect and
process food to deposit lipid during periods of food abundance in order to use in
times of food scarcity which was possibly frequently happening in ancient times
(Neel, 1962, 1999a, b) (Figure 3).

9

According to the hypothesis, the 'thrifty' genotype was advantageous for
hunter-gatherer populations, especially for women, because it would allow them
to fatten more quickly during times of abundance (Neel, 1962). Fatter individuals
carrying the thrifty genes would thus better survive times of food-scarcity.
However, in modern societies with a constant abundance of food, this genotype
prepares individuals for a famine that never comes. When you combine the
current environment with the sedentary lifestyle of today, the result is widespread
chronic obesity and related health problems like diabetes (Neel, 1999a, b).

The central principle of the thrifty gene hypothesis that famines were
common and severe enough to select for thrifty genes in ancient times has been
challenged by several researchers. It was argued that many of the populations
that later developed high rates of obesity/diabetes seemed to have no history of
famine (Speakman, 2008). A common example is the Pacific Islanders whose
tropical islands had plentiful vegetation and fish. One other significant problem for
the 'thrifty gene' idea is that it predicts that modern hunter gatherers should get
fat in the periods between famines, which was not the case in African/Australian
hunter-gatherers (Speakman, 2008).
Energy Homeostasis and Body Mass Regulation
Body weight is relatively stable over decades for many adults, implying
that it is under strict control through life. In fact, one study shows that males, on
average gains only 0.3-1kg per year, indicating that approximately 99.8% of the
calories are spent (Weigle, 1994). This suggests that calorie intake is strictly
10

balanced with the energy expenditure, keeping the weight within a small range.
Consistent with this notion, perturbations to the animal’s normal body weight
cause a counter reaction by altering food intake and energy expenditure.
Rodents who have gained weight through overfeeding, once ad libitum, decrease
the food intake and increase energy expenditure until the weight is normalized
(Cohn and Joseph, 1962). Conversely, mice that are food restricted, once ad
libitum, increase the food intake until the weight is normalized (Rothwell et al.,
1982; Rothwell and Stock, 1982). Similar observations have also been made in
both lean and obese humans. Obese individuals on strict diets, regain the lost
weight in the long run (Drenick et al., 1977; Johnson and Drenick, 1977). All
these studies suggest that there is a regulatory system that keeps body weight
stable at a “set point” upon changes in food intake/energy expenditure.
The system that changes food intake acts through hypothalamus based
on many studies. Firstly, many hypothalamic tumors are associated with obesity
or cachexia (Bauer, 1954). Furthermore, bilateral lesions of VMH region of
hypothalamus are associated with increases in fat tissue. These active lesions
also cause hyperphagia, causing obesity (Powley and Keesey, 1970). These
evidences suggest that body weight and energy balance in mammals is
controlled by a negative feedback loop including central nervous system and
peripheral organs. Lipostasis theory, first proposed by Kennedy and colleagues,
states that metabolites/signals/humoral factors from adipose tissue inform the
brain about the energy status of the body and any divergence from the
hypothetical “set point” causes changes in calorie intake/expenditure, keeping
11

the body weight in limits (Kennedy, 1953). The possibility of a secreted factor
was later shown to be true through parabiosis experiments as explained below.
A circulating factor for Lipostasis
ob (obese) and db (diabetes) animals have identical phenotypes on the
same genetic background. They are hyperphagic, show decreased energy
expenditure and develop early obesity accompanied with hyperinsulinemia,
sterility and thermoregulatory defects. Since
the metabolic profiles were identical, these
two putative genes were suggested by
Coleman to be genetically linked and
postulated to be part of the same pathway
(Coleman, 1978).
The evidence to the link between db
and

ob

gene

came

from

parabiosis

experiments (Figure 4). Parabiosis is a
surgical procedure where two animals are
Figure 4: Parabiosis experiments
performed by Coleman

joined through peritoneum and scapula
creating a capillary graft between animals,

Parabiosis experiments performed by
Coleman led to the discovery of leptin
gene. (Coleman, 1978)

hence allowing the direct exchange of

blood. Interestingly, when Coleman performed the parabiosis between an ob
animal and a wild type, ob animal gained much less weight compared to ob
animal parabiosed to another ob animal. This suggested the existence of a blood
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–borne factor that is absent in ob animals and present in wild types. When db
animals are parabiosed to wt animals, Coleman did not see any change in db
animals

(Coleman,

1978).

Conversely,

wild

type

animals

died

of

hypophagia/starvation in 50 days. Similarly, ob animals parabiosed to db animals
became hypophagic, lost adipose stores and died of starvation as was the case
for wild type animals.
Based on the abovementioned experiments, Coleman postulated that ob
animals were lacking a factor that was present in wild type animals; further db
animals were resistant to this secreted factor. Coleman reasoned that db gene
product was the receptor for this humoral/secreted factor, which was negatively
regulating body weight and missing in ob animals.
Additional evidence came from studies where VMH-lesioned obese rats
are parabiosed to normal rats. In this setting, normal rats became hyperphagic
and lost weight (Hervey, 1959). All together the evidence suggests that there is a
blood-borne humoral factor and a receptor which possibly is expressed in
hypothalamus.
Cloning of leptin and leptin receptor
The circulating factor that was missing in ob animals was successfully
cloned using a positional cloning strategy by Jeffrey Friedman and his
colleagues. Ob gene was found to be expressed predominantly in white adipose
tissue and to encode a 167 aa protein (Zhang et al., 1994).

Friedman and

colleagues found that C57BL/6J ob/ob carries a nonsense mutation at codon
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105. In ob/ob mouse, a transposon is inserted into the first intron and prevents
mature ob RNA to be expressed.
In 1995, the leptin receptor was identified biochemically and later shown to
be a cytokine family receptor with broad expression by Tartaglia et al. (Tartaglia
et al., 1995). It was later shown that leptin receptor RNA was alternatively spliced
and that only one of the splice variants, referred to as ObRb , was mutant in
C57Bl/Ks db/db mice (Lee et al., 1996). Among the leptin receptors ObRb was
highly enriched in the hypothalamus in precisely those nuclei that alter body
weight when lesioned (See above) (Fei et al., 1997; Lee et al., 1996). This
genetic evidence proved the Coleman hypothesis, that leptin acted on the
hypothalamus to control food intake and body weight. In parallel with the
evidence, injections or infusions of leptin reduce food intake and body weight of
wild-type and ob mice but have no effect on db mice (Campfield et al., 1995;
Halaas et al., 1997) (Figure 5).
Leptin action
Leptin primarily acts on a set of neural pathways in hypothalamus.
Basically, it activates pathways that inhibit food intake and inhibits pathways that
activate food intake (Figure 5). A significant part of leptin's actions seem to result
from inhibition of neuropeptide Y/Agouti gene-related peptide (NPY/AGRP)–
expressing neurons in the arcuate nucleus, a region in hypothalamus. These
neurons stimulate appetite. On the other hand, leptin was also shown to activate
pro-opiomelanocortin (POMC) neurons that reduce appetite by activating the
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MC4 receptor in other parts of the brain (Friedman, 1997). It is very likely that
there are other neural pathways that account for the full effect of leptin treatment.
The identification of these extra circuits would provide extra understanding for
delineating

the

mechanisms.

It

become

molecular
has

apparent

recently

that

leptin

signaling has important modulator
effects on dopaminergic neurons.
These neurons are possibly a part
of reward pathways that provide

Figure 5: Leptin and Lipostasis
Leptin is secreted by adipose tissue relative to the
amount of lipid stored. It acts on hypothalamus
and changes food intake and energy expenditure
to stabilize the body weight. (Courtesy of Jeffrey
Friedman)

inputs to the nucleus accumbens
(Hommel et al., 2006).

Leptin

also

acts

on

metabolism independently of its effect on body weight regulation. Leptin
decreases glucose/ insulin levels in ob/ob mice independent of the weight loss as
assessed by using very small doses (Pelleymounter et al., 1995). Some of the
peripheral effects of leptin are still unknown if they are mediated directly on
peripheral targets or through CNS. Leptin also increases sympathetic nerve
activity in several peripheral tissues (Haynes et al., 1997).
Regulation of leptin gene
The leptin gene is expressed predominantly in the fat tissue (Birsoy et al.,
2008; Maffei et al., 1995a). Furthermore the expression is very highly correlated
15

with the amount of fat mass as shown in many independent studies (Guo et al.,
2004; Lonnqvist et al., 1997; Maffei et al., 1995b; Skurk et al., 2007). Obese mice
such as ob/ob and high fat-fed models have elevated leptin mRNA levels (Maffei
et al., 1995a). Conversely, lipodystrophic/fasted animals have lower leptin mRNA
levels (Reitman and Gavrilova, 2000). Of importance, differences in leptin mRNA
levels, as assessed using in situ hybridization, show marked differences in the
levels of leptin RNA/cell as fat cells get larger or smaller (Maffei et al., 1995a).
This correlation holds true in comparisons of adipocytes in obese vs. lean
adipose depots, adipose tissue in fed vs. fasted in animals, comparisons among
different adipose depots that vary with respect to adipocyte cell size and finally
comparisons of leptin expression in fat cells in vitro vs. in vivo.

The strong

correlation between leptin gene expression and adipocyte size supports leptin's
physiological role as a humoral signal of fat mass (Skurk et al., 2007).
Leptin is regulated by many other metabolic cues. Glucocorticoids directly
stimulate leptin synthesis in adipocytes (Murakami et al., 1995). Leptin synthesis
is also increased by infection/ endotoxins and cytokines such as TNF and and
interleukin 1 (IL-1) (Bornstein et al., 1998; Sarraf et al., 1997). Conversely,
administration of thyroid hormone decreases leptin levels in rodents (EscobarMorreale et al., 1997).
Previously, changes in membrane cholesterol concentration related to
adipocyte size have been proposed as regulators of gene expression in
adipocytes. However, manipulation of cholesterol concentrations in 3T3-L1
adipocytes does not alter leptin gene expression but does change expression
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patterns of several other genes, including TNF-alpha (Le Lay et al., 2001). Thus,
the mechanism underlying the strong correlation between leptin gene expression
and adipocyte volume are unknown and identification of the transcriptional
mechanisms that regulate leptin could shed light on these questions.
While several prior reports have identified leptin promoter elements that
respond to secretagogues such as insulin, glucocorticoids, endotoxins and
thiazolidinediones,(Kolaczynski et al., 1996; Nolan et al., 1996; Zhang et al.,
1996) the factors that confer fat specific expression of the leptin gene and that
regulate its expression in parallel with changes in fat mass are not known.
Specifically, it is not known which trans-acting factors are responsible for the
induction or repression of leptin gene expression. Studies of the mouse, rat and
human leptin promoter are limited, but have identified C/EBP alpha, Sp1, and
Lp1 as playing roles in the regulation of leptin (de la Brousse et al., 1996; He et
al., 1995; Hwang et al., 1996; Isse et al., 1995; Mason et al., 1998). These
studies have all largely been done using leptin promoter constructs transfected
into cell lines. However, leptin expression is ~100 times lower in in vitro
differentiated adipocyte cell lines compared to tissue levels (Mandrup et al.,
1997a). Surprisingly, these adipocyte cell lines abundantly express the master
regulator PPARƔ, C/EBPβ, delta and alpha and their targets. Furthermore, these
transcription factors are also expressed in vivo in adipose tissue. This supports
that the adipocyte-specific expression of leptin is controlled by a different
transcriptional mechanism than the conventional adipocyte regulators (Soukas
et al., 2001b).
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Although the abovementioned experiments have shed light into some of
the trans-acting factors which can affect the transcription of a reporter gene
attached to leptin promoter in vitro, whether these factors regulate leptin gene
expression in-vivo is not established.
Fat tissue biology
Fat tissue was long believed to be an inert depot for the storage of energy.
This view was upended in 1994 by the discovery of the hormone leptin, which is
secreted by adipocytes and signals to the brain to control body weight (Zhang et
al., 1994). The intervening 15 years
have led to the discovery of a
complex cross-talk between adipose
tissue

and

regulate

other

metabolism

weight

organs

that

and

body

(Farmer,

2006b).

Nonetheless, our understanding of
the biology of fat itself remains
Figure 6: Adipose tissue is composed of
different cell types

limited. Understanding how adipose

This figure shows the adipose tissue whole mount
microscopy from transgenic animals expressing
GFP only in adipocyte nuclei. Red shows the
capillaries. Note the GFP- DAPI+ stained nuclei,
which represents the non-adipocyte cells.

obesity and metabolic diseases.
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tissue

mass

regulated

in

is

generated

vivo

has

and
major

implications for the treatment of

Adipose tissue is a complex and essential endocrine/energy-storing organ.
Besides adipocytes, adipose tissue contains connective tissue matrix, nerve
tissue, stromovascular cells, and immune cells (Rosen and MacDougald, 2006)
(Figure 6). Together, these components function as an integrated unit. Adipose
tissue not only responds to afferent signals from CNS and other systems but also
expresses a wide variety of peptides, known as adipokines, which function at
both the local (autocrine/paracrine) and systemic (endocrine) level. Up to this
date

many

secreted

factors

are

discovered,

including

leptin,

resistin,

plasminogen activator inhibitor-1, and adiponectin. Through this interactive
crosstalk, adipose tissue is involved in many biological processes including
energy metabolism, immune function and neuroendocrine function.
Fat is an integral organ to the whole organism. As with other essential
organs, excess amount (obesity) as well as lack of it (lipodystrophy) cause
adverse metabolic consequences. Excess adipose tissue, obesity, is associated
with

hyperglycemia,

insulin

resistance, dyslipidemia,

hypertension,

and

inflammatory states (Kopelman, 2000a). Conversely, adipose tissue deficiency or
lipodystrophy is also associated with features of the metabolic syndrome in both
humans and rodents (Gesta et al., 2007) (Hegele, 2000).
In mammals there are different fat depots, having different roles (Kissebah
and Krakower, 1994). The main fat organs are subcutaneous and visceral
adipose depots. These depots are responsive to energy stores and many
hormonal/metabolic changes in an organism. There are also structural fat depots
that can be found in many other areas, including in the retro-orbital space, on the
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face and extremities, around breasts/thighs and within the bone marrow. Many of
these areas are not responsive to energy level of the body. In addition, some
adipose organs are responsive to sex hormones, such as adipose tissue in the
breasts and thighs, whereas other depots, such as scapular fat, are responsive
to glucocorticoids (Gesta et al., 2007).

The evolution of the complexity of

different depots possibly emerged with the endothermic animals, where there is a
need of energy for strict thermoregulation (Gesta et al., 2007). Next section
discusses the evolution of fat depots.

Figure 7 : Evolution of fat tissue
Fat tissue distribution has changed in the course of evolution. (Gesta et al., 2007)

Evolution of Adipose Tissue
Almost all species, from simple invertebrates to Homo sapiens store their
excess energy in the form of lipids (Figure 7). However, the cell type that stores
the lipid differs from organism to organism relative to the complexity. For
instance, C. elegans store fat in intestinal epithelium and sharks store fat in the
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hepatocytes (McKay et al., 2003; Van Vleet et al., 1984). With the evolution of
vertebrates, a special organ for storing fat appears- the adipose.

Adipose tissue distribution and fat storage changed dramatically with the
process of evolution. As explained above, even small invertebrates such as
worms and flies store lipids at some point in their life cycles; however adipose
tissue evolved with the emergence of boney fish, teleostei. Of note, intraabdominal white adipose tissue co-evolved with the adipocyte hormone- leptin- in
boney fish (Figure 7). With the emergence of endothermic animals, differentiation
of subcutaneous and internal WAT occured in higher species, such as birds and
mammals. This further complexity possibly started due to the need to strictly
stabilize the body temperature in endothermic animals. It is important to note that
even though leptin seems to have coevolved with the adipose organ, adipose
tissue is not the only organ to express leptin in the exothermic vertebrates (Gesta
et al., 2007). Furthermore, there is very little evidence that leptin affects these
exothermic animals the same way as it does mammals. Leptin, in exothermic
animals such as frogs, fish and several reptiles, has been found to act on other
functions such as the metamorphosis and development of these animals
(Gorissen et al., 2009; Huising et al., 2006). This evidence suggests that the role
of leptin as the signal for energy stores might have evolved with endothermia.
Adipogenesis
Adipogenesis is defined as the differentiation of adipocytes, which are
committed for adipogenic lineage, into mature adipocytes (Rosen and
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MacDougald, 2006; Rosen and Spiegelman, 2006). During the last 20 years, with
the availability of adipogenic cell lines, a great deal of new information was
learned about adipogenesis and transcriptional events regulating adipocyte
differentiation (adipogenesis). Although many cell types may contain lipids, the
unique property of adipocytes is that they can store a much greater volume of
lipids, and further can release of these calories for use by other organs. For this
reason, studying adipocyte differentiation specifically has clinical value to
understand several metabolic diseases including obesity and lipodystrophy.

Adipocytes are possibly differentiated through 2 phases. The first phase is
the commitment of a pluripotent stem cell to the adipocyte lineage, also known as
the determination step (Rangwala and Lazar, 2000). After the determination,
stem cell loses the potential to differentiate into other cell types and committed to
adipocyte lineage. In the second phase, which is known as terminal
differentiation, the pre-adipocyte takes characteristics of the mature adipocyte.
The molecular regulation of differentiation is more extensively studied than
determination because most studies make use of adipogenic cell lines that have
a restricted potential to differentiate into other cell types (Rangwala and Lazar,
2000).

Predetermination type of the above-mentioned in vitro model systems
include the NIH-3T3 and the C3H10T1/2 cell lines, which are supposedly
pluripotent and can therefore be differentiated into many different lineages such
as adipocytes, osteocytes, or chondrocytes (Rosen and MacDougald, 2006).
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Other cell line models, such as the 3T3-L1 and 3T3-F442A are already
committed to the adipogenic pathway, therefore considered to be preadipocytes
(Green and Meuth, 1975). These cell lines were originally established by Green
and colleagues, which have greatly facilitated our knowledge of the molecular
mechanisms controlling adipogenesis (Green and Meuth, 1975). Confluent 3T3L1 preadipocytes are differentiated upon exposure to the adipogenic inducers
fetal bovine serum (FBS), dexamethasone, isobutylmethylxanthine, and insulin.
3T3-L1 preadipocytes differentiate into adipocyte through three steps. First, the
cells go through a growth arrest at confluence, which is required for the initiation
of differentiation events. Secondly, after addition of the hormone cocktail, cells
synchronously enter into S phase of the cell cycle, through one or two rounds of
mitosis, a step also known as clonal expansion. Finally PPARƔ, C/EBPα, and
many of the adipocyte markers are expressed and the cells get their
characteristic rounded morphology and accumulate lipid droplets, also known as
terminal differentiation (Rangwala and Lazar, 2000).

The validity of the 3T3 preadipocyte system as an appropriate model of
adipocyte formation has been accepted by many researchers due to the similarity
of genes expressed in vitro vs in vivo adipocytes. Furthermore, injection of 3T3F442A preadipocytes into mice gives rise to normal fat pads (Mandrup et al.,
1997a). Despite this knowledge, the lack of a robust in vivo adipogenesis model
hinders the comparison. The preadipocyte cells and in vivo characteristics of the
cell types are unknown.
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Molecular processes involved in adipogenesis
Differentiation of preadipocytes into adipocytes is regulated by a complex
and temporally regulated network of transcription factors that coordinate
expression of hundreds of proteins responsible for establishing the mature fatcell phenotype (Figure 8). To this date, two principal adipogenic factors, PPARƔ
and C/EBPβ, are thought to be the late and early master regulator of the
adipogenic process respectively (Lefterova and Lazar, 2009). PPARƔ especially
is

considered

the

master

regulator

of

adipogenesis,

because

precursor/preadipocyte cells are incapable of expressing any known property of
the fat cell phenotype without PPARƔ (Tontonoz et al., 1994a; Tontonoz et al.,
1994b; Tontonoz et al., 1994c; Tontonoz et al., 1994d).

Much of our knowledge of the adipogenic network and the importance of
PPARƔ and C/EBPβ come from studies performed in established preadipocyte
cell lines as discussed previously. Even though animal data for these two genes
gave several indications of their role, (Jones et al., 2005b; Tanaka et al., 1997) it
is especially hard to knock out these genes at the right temporal point due to the
lack of the early markers and some of the genes such as C/EBPs have other
roles in other cell types and development, causing embryonic/ postembryonic
abnormalities when knocked out (Bai et al., 2006).

The late master regulator PPARƔ was discovered by Bruce Spiegelman
and colleagues by studying the regulators of aP2 gene (Graves et al., 1992;
Tontonoz et al., 1994a). Spiegelman group identified an enhancer fragment that
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regulates aP2 expression and consequently isolated the factor from adipose
extracts using this fragment. This factor turned out to be PPARƔ, which is
expressed in a fairly fat specific fashion. PPARƔ is expressed in two forms,
namely g1 and g2. Among these forms, g2 is found selectively in adipose tissue,
whereas g1 is found also in other tissues. PPARƔ is a nuclear receptor and like
other PPARs heterodimerize with RXR and activates its target promoters
(Mueller et al., 2002). Strong activation of PPARƔ requires the binding of an
unknown endogenous agonist. When overexpressed, PPARƔ is sufficient to drive
adipogenesis and no factor has been discovered promoting adipogenesis in the
absence of PPARƔ.

In vivo, inducible knockout of PPARƔ in differentiated

adipocytes leads to adipocyte death followed by generation of new adipocytes
(Jones et al., 2005b). This suggests that PPARƔ is also important for
maintenance of the differentiated adipocyte state (Tontonoz et al., 1994d).
Several C/EBP family members, including CEBPa, C/EBPβ and C/EBPδ
were also shown to be crucial for adipogenesis (Figure 8). The temporal
expression of these factors during adipocyte differentiation indicates a cascade
where early induction of C/EBPβ and C/EBPδ leads to induction of C/EBPα and
PPARƔ (Lefterova and Lazar, 2009).
Among the early factors C/EBPβ seems to be indispensible for
adipogenesis in immortalized pre-adipocyte lines (Hamm et al., 2001; Tang et al.,
2004). C/EBPβ-deficient mice have reduced adiposity (Tanaka et al., 1997).
C/EBPβ promotes adipogenesis at least in part by inducing C/EBPα and PPARƔ
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(Zhang et al., 2004b). Consistent with this, C/EBPβ- deficient MEFs do not
express C/EBPα and PPARƔ.

Figure 8: Transcriptional Regulation of Adipogenesis
Adipogenesis occurs through expression of a complex and temporally regulated transcriptional
network. Adapted from Rosen, 2006

Apart from C/EBPs and PPARƔ, there are other factors that are known to
be involved in adipogenesis. Among these, KLF factors seem to have variety of
roles. The range of KLF genes that are expressed in adipose tissue, the
variability in their expression patterns during adipocyte differentiation, and their
effects on adipocyte development and gene expression indicate that a cascade
of KLFs function during adipogenesis (Rosen and MacDougald, 2006). Another
recent study has characterized expression changes in all nuclear-receptor family
members in 3T3-L1 adipogenesis (Fu et al., 2005). Several members of this
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family, including the glucocorticoid receptor, are known to affect adipogenesis,
but this study indicates that many others could potentially regulate this process.
GATA-binding transcription factors GATA-2 and GATA-3 also play a critical role
in the molecular control of the preadipocyte-adipocyte transition (Tong et al.,
2000). GATA-2 and GATA-3 are expressed in white preadipocytes, and their
mRNAs

are

downregulated

during

adipocyte

differentiation.

One

other

transcription factor, CREB, is constitutively expressed prior to and during
adipogenesis (Zhang et al., 2004a). Overexpression of a constitutively active
CREB in 3T3-L1 preadipocytes is necessary and sufficient to initiate
adipogenesis, whereas overexpression of a dominant-negative CREB alone
inhibits adipogenesis.

CREB

phosphorylation,

an

event

necessary

for

adipogenesis, is possibly among the earliest modifications in adipocyte
differentiation upon hormone induction at least in vitro (Reusch et al., 2000b;
Zhang et al., 2004a).

During the terminal phase of differentiation, activation of the transcriptional
cascade leads to increased activity, protein, and mRNA levels for enzymes
involved in triacylglycerol synthesis and degradation. Along with the lipid
accumulation, synthesis of adipocyte-secreted products including FABP4,
adipsin, resistin, and adipocyte-complement-related protein (Acrp30) begin,
producing a highly specialized endocrine/energy-storing cell that will play key
roles in various physiological processes (Rosen and MacDougald, 2006).
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Adipose tissue development in vivo
Up to this date, origins of adipose tissue in terms of its location and
possible progenitor cell types have not been fully characterized and precise
lineage tracing studies have not been performed. Even though adipose is
generally accepted as having a mesodermal origin, this theory has not been
tested or studied and is based on the fact that fibroblastic cell lines and MEF
cells can differentiate into adipocytes in vitro (Rosen and MacDougald, 2006).
White

adipose

tissue

can

hardly

be

detected

macroscopically/microscopically during embryonic life and at birth in rodents (rat,
mouse) due to the lack of cell markers and lack of lipid accumulation. The
development of white adipose tissue has been studied extensively in pig fetuses
in early 1980s (Hausman et al., 1981). These studies show that approximately
the beginning of the second third of the gestation period in pigs, an extensive
vasculature and developing fat cell clusters can be observed, which are
surrounded by extensive stroma (Ashwell et al., 1987; Hausman, 1985; Hausman
et al., 1981; Hausman et al., 1984; Hausman and Thomas, 1984). The embryonic
development of human adipose tissue takes place earlier than that of the pig in
various sites (Fritsch and Kuhnel, 1992; Labbe et al., 1989).
Based on the above-mentioned studies, adipose tissue appears and
develops in the areas where it remains after birth. Initially, a dense mass of
mesenchymal cells with no lipid accumulation occurs. Vascularization and
accumulation of lipid possibly follows this process.

Interestingly, after the

development of fluorescent markers and microscopic analysis, there is almost no
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study on the development of adipose tissue up to this date. The idea that
developmental and patterning genes might play a role in the differential
development of various adipose tissue depots has been suggested by several
recent studies (Vohl et al., 2004) (Gesta et al., 2006). These studies show that
several patterning genes mainly from Hox families might have roles in in vivo
adipose development.

The adipose organ is composed of cells with different functions that most
likely arise from different developmental lineages. Although the field of adipocyte
biology has made great progress in vitro, we still lack markers capable of
distinguishing preadipocytes that can define various stages in the differentiation
process in vivo. Specifically, cell types, markers, morphology and anatomic
location of these cell types before and after the determination step are not
known. Identification characterization of these different cell types could provide
new treatments for obesity and its complications. Even though it is widely
controversial, some groups suggest that these preadipocytes might derive from
blood lineage (Crossno et al., 2006). The defining experiments including a FACS
sorting and characterization of different preadipocyte lineage from adipose tissue
are lacking.

Regarding the preadipocyte markers, the only widely accepted marker of
preadipocytes is preadipocyte factor 1 (Pref-1; also known as DLK-1 or
Drosophila Homolog-like 1) (Villena et al., 2002). Pref-1 is expressed at high
levels in both white and brown preadipocytes, and expression markedly
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decreases upon differentiation. Pref-1, however, is not unique to the
preadipocyte and is also expressed in other tissues such as placenta, pituitary,
adrenal cortex, fetal liver and pancreatic islet cells. Pref-1 is synthesized as a
transmembrane protein and is cleaved to generate a soluble form that acts to
inhibit adipocyte differentiation. Mice lacking Pref-1 show accelerated fat
deposition, (Moon et al., 2002). Despite this, it is not known what type of
preadipogenic cell types express Pref-1.
Adipogenesis and Diseases
The increase in adiposity in obese individuals may result from an increase
in both adipocyte number and size of individual fat cells (Rosen and
MacDougald, 2006). Disproportionate increase in the visceral adipose depots in
some individuals is thought to be linked to development of certain metabolic
disorders. Understanding the mechanisms regulating fat tissue formation should
have implications for treatment of obesity.

It is generally regarded in clinical medicine that adipocyte number of a
person is determined just after birth and stays constant through life. This notion
however is not based on any experimentation. In fact, several rodent models of
obesity have increased adipocyte size, numbers or both (Cleary et al., 1979).
Adipogenesis probably continues throughout life at a low rate until energystorage demands promote further differentiation. A very interesting data came
recently from Spalding and colleagues on this issue. Spalding and colleagues'
results show that fat cells have a high turnover such that new cells are
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continually being born to replace their dead predecessors. The average age of a
fat cell seems to be about 10 years in both lean and obese individuals, and the
number of fat cells as a proportion of all cells remains constant in each weight
group. But the total number of new fat cells is higher in obese subjects,
suggesting that they are replenishing an existing larger pool. This suggests that
adipocyte hyperplasia might have more impact on obesity than recently
appreciated (Spalding et al., 2008).
One other disease related to adipocyte differentiation is lipodystrophy.
When adipocytes are absent, in these patients, lipids accumulate in muscle, liver
and other peripheral locations. This causes insulin resistance and steatosis that
leads to cirrhosis (Herranz et al., 2008; Reue and Peterfy, 2000; Thiebaut et al.,
2000). In addition, due to the lack of adipose, some of these patients have
extremely low levels of leptin and other adipokines, which was lately considered
to be the cause for insulin resistance and diabetes. Consistent with this, leptin
treatment of patients with congenital lipodystrophies improved these metabolic
abnormalities associated with their disease (Oral et al., 2002; Wolfsdorf et al.,
2002). Several genetic causes of lipodystrophy have been discovered in the past
few years. Some of these mutations include adipogenesis related genes such as
PPARƔ and AGPAT2 (Rosen and MacDougald, 2006). Similarly, overexpression
of dominant negative C/EBP and mutation of lipin-1 causes lipodystrophy in
genetically engineered mice (Peterfy et al., 2005).
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CHAPTER 2:
Materials and Methods
Animal Experiments:
7 to 8 week old C57Bl/6 mice were purchased from the Jackson
Laboratory, individually caged, and allowed to acclimate. All experiments were
performed according to Rockefeller University CBC guidelines under protocol
number 06055.
Leptin treatment procedure is performed as previously described using
Alzet subcutaneous pumps. Wild type animals are treated leptin at 2.5 µg/hour
and ob/ob animals are treated 150ng/hour. Animals were PBS (6) or leptin (6)
treated as described (Cohen et al., 2002).

Animals were sacrificed and fat

tissues were isolated. Fat tissue from each animal were dissociated by 1.5mg/ml
collogenase in Krebs-Ringer buffer as described.(Soukas et al., 2001a) RNA was
isolated from stromavascular fraction and TAQMAN RT-PCR was performed.
For leptin withdrawal experiment, PBS (PBS control group) or leptin at 2.5
µg/hour (Leptin-FF and Leptin-NC groups) or was administered for 8 days by
subcutaneous implanted osmotic pump (Alza, Palo Alto, CA). On day 8, leptin or
PBS treatment was withdrawn by removing pumps under inhaled anesthesia.
Body mass and food intake were monitored daily at 1200h. Animals were freefed (Leptin-FF and PBS groups) or maintained at the level of food intake prior to
leptin withdrawal (Leptin-NC group). Mice were sacrificed at 1200 h on days 6
and 8 of leptin treatment (PBS and Leptin groups) and 1, 2, 3, and 4 days after
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pumps had been withdrawn (PBS, Leptin-FF and Leptin-NC groups). Serum and
peri-uterine white adipose tissue were collected and kept at -80 °C for later
analyses. Serum leptin (R&D Systems, Minneapolis, MN) and insulin (Crystal
Chem, Chicago, IL) were measured by ELISA according to the manufacturers
protocols.
BAC modifications and in-vitro / in vivo imaging:
Modification of BACs has been performed as described (Warming et al.,
2005) (Gong et al., 2003). Firefly luciferase is from Promega. Generation of
transgenic mice following microinjection was based on standard techniques
described by Hogan and colleagues (Hogan B. , 1994). In each case, leptin
luciferase animals were killed and tissues; fat, spleen, kidney, brain, colon, liver,
intestine, heart were isolated and lysed in passive lysis buffer (Promega).
Luciferase activity was measured using Luciferase Assay Kit (Promega). Protein
normalization was performed after protein measurements using the BCA (Pierce)
kit according to the manufacturer’s instructions.
In vivo imaging of transgenic animals was performed using the Xenogen
IVIS Lumina imaging system. Anesthetised animals were injected intraperitonally
with the luciferase substrate, luciferin (200 μl of stock 15 mg/ml in PBS). After 1520 min, the animals were placed in a dark imaging chamber under isoflurane
anesthesia. Photon emission resulting from the luciferin/luciferase reaction was
detected with a sensitive CCD camera. This photon image was superimposed on
a normal video image of the mouse with Living Image 3.0 software (Xenogen).
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White Adipose Tissue Histology and Glycogen Quantitation:
Tissue fragments were embedded in paraffin wax (Paraplast Plus, Fisher
Scientific, Morris Plains, NJ). Sections were PAS stained and hemaxoxylin
counterstained according to standard protocol (Sigma). To demonstrate
specificity of glycogen staining, several sections were pre-incubated for 5
minutes at 37 °C in 5 mg/ml α-amylase (Sigma) after re-hydration prior to PAS
staining. Glycogen was quantitated with the amyloglucosidase method.(Keppler,
1974) For periodic acid-schiff (PAS) staining, to avoid loss of water soluble
glycogen, small pieces of tissue (50 mg) were incubated overnight in alcoholic
fixative (90% ethanol, 10% formaldehyde).
Plasmids:
For overxpression studies, KLF4 cDNA was cloned by RT-PCR and an HA
epitope was added at the C terminus. It was subsequently inserted into
pMSCVpuro (Clontech). Other pMSCV vectors are as used in Chen et al (Chen
et al., 2005a). FLAG-KLF4 is courtesy of Douglas Boyd.
For knockdown of KLF4, Krox20 or C/EBPβ expression in 3T3-L1 cells,
the DNA-based, retroviral vector-mediated siRNA technology was used. The
targeted sequence was determined by the Whitehead Institute siRNA designing
tool and verified by BLAST searches to ensure specificity. Two complementary
oligos for each targeted sequence were then designed according to the protocol
of Clontech’s RNAi-Ready pSIREN-RetroQ system, annealed, and ligated into
the BamHI/EcoRI-linearized pSIREN-RetroQ vector. The resulting plasmid, upon
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packaged into retrovirus, allowed stable expression of siRNA hairpin for a
specific gene. All sequences for the siRNA constructs are as described in Chen
et al (Chen et al., 2005a).
Retroviral infections and 3T3-L1 differentiations:
Recombinant pMSCV or pSIREN-RetroQ viral packaging was achieved by
transfection of the plasmid into Phoenix ecotropic packaging cells (cultured in
DMEM with 10% FBS in 5% CO 2 ) using Fugene6 (Roche). Viral supernatants
were supplemented with 8 μg/ml polybrene and added to cells for infections for
18–24 hr. Cells were selected with 2μg/ml puromycin or 100 μg/ml hygromycin
(Sigma), expanded, and seeded for differentiation experiments.

3T3-L1 cells

(ATCC) were maintained in DMEM with 10% FBS (Invitrogen) in 5% CO 2 . Stable
cell lines from retroviral transduction were cultured to confluence and exposed to
the differentiation cocktail (1 μg/ml insulin, 0.25 μg/ml dexamethasone, 0.5 mM
IBMX). After 48 hr, cells were maintained in medium containing 1 μg/ml insulin
until day 8 for harvest.

Plates were oil-red O stained as described earlier

(Soukas et al., 2001a). In experiments, where each component is added
separately or in groups, the concentrations are as in the standard hormone
cocktail.
Coimmunoprecipitation
293T cells grown in DMEM supplemented with 10% FBS were transiently
transfected

using

Fugene6

(Roche)

according

to

the

manufacturer’s

recommendations. Transfected cells were harvested in BA300 buffer (BA0 with
300mM NaCl) after 36h, and lysates were used for coimmunoprecipitation as
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described (Dou et al., 2005). Briefly, lysate expressing indicated plasmids were
immunoprecipitated by M2 agarose beads (Sigma) and washed extensively for 3
times. Beads were denatured with SDS-PAGE loading dye, and supernatants
were separated on 12% SDS-PAGE gels and western blotting was performed by
anti-HA. (Sigma-H6908)
RT-PCR analysis
Total RNA was isolated from cells by QIAGEN RNA prep kit following
TRIZOL reagent (Invitrogen). Real Time PCR was performed by the Taqman
system (Applied Biosystems) according to the manufacturer’s instructions. Oligos
were designed by the PrimerExpress software. Amount of expression was
normalized with cyclophilin for cell culture experiments and with ELK3 for
preadipocyte fraction experiments. Sequences of the Taqman primers and
probes are available in Supplementary methods.
Transfection and reporter assays.
C/EBPβ reporter was kindly provided by Daniel Lane.
made by PCR and cloned into pGL3 plasmid.

Deletions were

(Primers are available upon

request.) The reporter plasmids along with effector plasmids were transfected
using Fugene6 into 293T cells at 80-90% confluence. The pRL-TK (Promega)
that carries Rennila luciferase was also cotransfected as an internal control for
transfection efficiency. Cells were harvested after 20-24h and luciferase activities
analyzed using the Promega Dual-Luciferase assay kit as recommended by the
manufacturer.
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GST pull-down:
KLF4 was cloned by PCR from pMSCVpuro-KLF4 and subsequently
inserted into pGEX-T1 plasmid to express GST-KLF4 protein. GST-KLF4 protein
is isolated as described (Morlon and Sassone-Corsi, 2003). In vitro transcription
and translation of the Krox20 protein was performed by using the TNT T7 quickcoupled transcription-translation kit (Promega).
GST pull-down assays were performed by incubating GST fusion proteins
immobilized on GST beads with in vitro-translated
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S-labeled Krox20 or

Luciferase. After washing, bound proteins were isolated by eluting the proteins
with 2× SDS buffer, separating them on SDS/PAGE, and developing by
autoradiography.
CHIP assays
ChIP assay Kit (Upstate Biotechnology, Lake Placid, NY) was used
according to the method recommended by the manufacturer, with minor
modifications.

In

brief,

a

plate

of

cells

was

fixed

in

the

presence

of1%formaldehyde for 10 min at room temperature. The reaction was stopped by
the addition of glycine at a final concentration 0.125 M. A soluble chromatin
fraction containing fragmented DNA of 500–2,000 bp was obtained after cell lysis
and sonication. The fraction was diluted ten times and precleared by using
Protein A agarose slurry.
Samples were incubated with Rabbit anti-KLF4 (santa cruz) or rabbit-IgG
as a control, later mmunoprecipitated and DNA was used for PCR.
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SDS-PAGE and Immunoblotting:
Proteins were separated by SDS-PAGE using pre-cast 4-20% or 12%
SDS gels (Bio-Rad) and transferred to nitrocellulose membranes. Western blot
has been performed as described (Boyer-Guittaut et al., 2005). Briefly, total
protein lysate (20–50 μg) was loaded on SDS-PAGE for each sample. Rabbit
anti-KLF4, rabbit anti-C/EBPβ, and mouse anti-TBP were from Santa Cruz (H180, C-19, and N-12, respectively). HRP-conjugated anti-rabbit and anti-mouse
secondary antibodies were from Amersham(GE).
Gel shift assays
EMSA was performed by incubating 5 ug of Nuclear extracts or 100ng of
purified protein at room temperature for 20 min in a 30-µl binding reaction mixture
containing 10 mM HEPES, pH 7.9, 80 mM KCl, 5% glycerol, 30 ng of poly(dI-dC),
75 ng of denatured salmon sperm DNA, 10 mM dithiothreitol, and 30,000 cpm of
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P-labeled double-stranded DNA probe. Following incubation, reaction mixtures

were loaded on a 5-7% polyacrylamide gel, dried, and subjected to
autoradiography.
A 500-fold molar excess of unlabeled probe was added for competition as
indicated in the appropriate figures. For competition experiments, proteins were
preincubated for 20 minutes at room temperature with unlabeled probe at
specified -fold excess. Labeled probe was then added and incubated for 20 min
at room temperature.
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Whole mount staining
Mice were sacrificed by cervical dislocation, after which the epididymal fat
was removed using sterile techniques and minced into small pieces (~2-3 mm)
using a scalpel. The tissue pieces were then washed and incubated with
LipidTox, and/or Griffonia simplicifolia isolectin GS-IB4 conjugated with Alexa
Fluor (Molecular Probes) before observation. Nuclei were counterstained with
Hoecst 33342 (Molecular Probes). Griffonia simplicifolia IB4 isolectin is
reportedly a useful histochemical probe that specifically labels endothelial cells in
many species and tissues, including adipose tissue.
Confocal microscopy
A confocal laser scanning microscope (LSM510 Meta; Carl Zeiss)
equipped with 10x dry, 40x dry, and 63x oil objectives was used to collect stacks
of images at regular intervals along the optical axis. The tissue was excited using
multiple color laser lines, and the emission was collected through appropriate
narrow band-pass filters. Each image was produced from an average of 8 frames
after which the acquired images were processed to produce a surface-rendered
3-dimensional model. In preliminary experiments, adipose tissue was observed
using 5-μm-thick stacks of images obtained at 0.5-μm intervals and 50-μm-thick
stacks obtained at 2-μm intervals.
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CHAPTER 3:
Transcriptional Networks in Early Regulation of Adipogenesis
Introduction
Two decades of research have revealed that adipogenesis is controlled by
a complex network of transcription factors, including numerous transcriptional
activators, coactivators and repressors (Farmer, 2006a). When confluent 3T3-L1
and 3T3-F442A cell lines are exposed to a cocktail of hormonal stimulants, these
cell lines accumulate lipid and develop the characteristic morphology of mature
adipocytes (Green and Meuth, 1975). The earliest inductive event in this process
is transcriptional activation of two of the C/EBP family of transcription factors,
C/EBPβ and C/EBPδ, which then stimulate expression of PPARƔ, the late major
transcription factor (Cao et al., 1991; Lane et al., 1999; Wu et al., 1995; Yeh et
al., 1995).

PPARƔ is necessary and sufficient for adipocyte differentiation

(Tontonoz et al., 1994d). Less is known about what controls C/EBP gene
expression. The identification of the factors that regulate these important early
genes in preadipocytes would provide additional insight into the mechanisms
regulating the initiation of fat cell differentiation.
In order to study the earlier transcription factors, it was considered that
these factors might be included in a panel of transcription factors that are
expressed at a much higher level in white adipose tissue in vivo than in 3T3-L1
cells in vitro. This approach yielded two early transcription factors, Krox20 and
KLF4.

However, a role of KLF4 in adipogenesis has not been previously
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demonstrated. KLF4, also known as GKLF/ZIF, is highly expressed in
differentiated, post-mitotic cells of the skin and the gastrointestinal tract and it
has been suggested to have variety of roles as differentiation-proliferation switch
and control of the cell cycle (Garrett-Sinha et al., 1996; Shields et al., 1996;
Takahashi and Yamanaka, 2006; Yoon et al., 2003). KLF4 knockout mice die
around 12 hours after birth due to defects in skin development with a failure of
normal basement membrane formation (Segre et al., 1999). In these mice, the
skin’s fat layer is disrupted, causing the loss of skin barrier function and rapid
loss of body fluids (Segre et al., 1999).
I thus considered the possibility that KLF4 might play a role in regulating
the development of adipose tissue and tested this possibility by studying the
functional role of KLF4 during the differentiation of 3T3L1 adipocytes.
Results
Several transcription factors are expressed highly in in vivo adipose
tissue compared to in vitro differentiated adipocytes
A previous microarray analysis has been done by Soukas et al in order to
characterize factors that might regulate leptin gene expression by comparing in
vivo versus in vitro adipocytes (Soukas et al., 2001a). However, since adipose
tissue also contains other cell types (stromavascular fraction), we considered the
possibility that early factors that are expressed in the stromavascular fraction
might be included in this panel of transcription factors that are expressed at a
much higher level in white adipose tissue in vivo than in 3T3-L1 cells in vitro
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(Soukas et al., 2001a). Among these transcription factors, Krox20 has been
characterized as one of the earlier factors, validating this microarray approach
(Chen et al., 2005b) (Figure 9).

Figure 9 In vivo enriched transcription factors.
This figure shows the in vivo adipose-tissue enriched transcription factors. Left side of the graph
shows the expression of each transcription factor during 3T3-L1 differentiation time course. WAT:
White adipose tissue

One of the other transcription factors that is induced in vivo is KLF4, a
member of a large family of zinc-finger proteins that is known to play important
roles in differentiation and proliferation (Ghaleb et al., 2005). Several other KLFs
have previously been implicated in the regulation of adipogenesis. KLF6 and
KLF15 have both been shown to promote adipogenesis and KLF15 also
upregulates GLUT4 expression (Boquest et al., 2005; Halaas et al., 2005). In
addition, another KLF factor, KLF5, is necessary for adipocyte differentiation and
acts by transactivating the PPARƔ2 promoter (Oishi et al., 2005). All these KLF
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Figure 10 Expression of KLF4 during 3T3-L1 differentiation
A) The expression of KLF4 during differentiation of 3T3-L1 cells was analyzed using Taqman RTPCR and (B) Western blots. Cells were harvested at the indicated times. Cyclophilin was used as
an internal control for Taqman analysis.
C) Expression of early genes in stromavascular fraction and adipocyte fraction. Taqman RT-PCR
was performed in stromavascular and adipocyte fractions of the adipose tissue disintegrated by
collagenase. Leptin levels (enriched in the adipose fraction) were checked as a control of the
preparation. Error bars are SEM.

factors are thought to function through different coactivators or repressors
(Farmer, 2006a).
KLF4 is an early-expressed and necessary factor during 3T3-L1
differentiation
To assess if KLF4 is an early factor, KLF4 gene expression was assayed
at numerous times early during 3T3-L1 differentiation that was induced using the
standard IBMX, dexamethosone, and insulin cocktail.
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Quantitative RT-PCR

revealed that KLF4 mRNA appeared 30 min post-induction and peaked at 2 hr
post-induction. Protein levels for KLF4 were consistent with the mRNA levels
(Figure 10). This result shows that KLF4 is expressed very early in the course of
3T3-L1 differentiation with a similar pattern to other previously described early
transcription factors (Figure 10) including Krox 20, C/EBPβ and C/EBPδ. These
same factors were also enriched in the stromal/pre-adipocyte fraction of the
adipose tissue compared to the adipocyte fraction (Figure 10C).

Figure 11 KLF4 is necessary for adipogenesis
KLF4 knock-down impairs adipogenesis. 3T3-L1 cells were infected with pSIREN-RetroQ-derived
retroviruses carrying either siRNA oligos for KLF4 or control oligo, selected for puromycin
resistance, expanded as mixed population and induced to differentiate using MDI cocktail. The
upper panel (A) shows the efficiency of the 2 knock-down plasmids against KLF4 by Taqman
assays. (B) Right panel shows expression levels of fat markers aP2, PPARƔ2, adipsin and an
early gene, C/EBPβ in control and KLF4 knock-down 3T3-L1 cell lines at different time points
during differentiation.
C) ORO staining of KLF4 knock-down and control hairpin cell lines at day 8.
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The role of KLF4 in adipogenesis was tested using retroviruses carrying
siRNA for KLF4, to knock down its expression. Two independent hairpin siRNA
sequences for KLF4 (cloned into pSIREN-RetroQ-puro retroviral plasmid) were
effective for knocking down KLF4 expression (Figure 11). 3T3-L1 cells were
infected with the two KLF4 siRNA-containing retroviruses along with a control
hairpin.

After selection with puromycin, we established stable cell lines with

constitutive siRNA expression. Note, these cell lines were a mixture of all cells
expressing the selectable marker and were not clonal. These stable cell lines
were cultured to confluence and differentiated using the standard induction
cocktail for 8 days. Oil red O staining revealed that both KLF4 knock down cell
lines accumulated significantly less lipid than the control cell line. (Figure 11C)
RNA levels of adipogenic regulators such as adipsin, ap2 and PPARƔ2 were also
reduced consistent with the oil red-O staining. In addition, early C/EBPβ
expression was also reduced in KLF4 knock down cell lines compared to control
cells (Figure 11B). These results suggest that KLF4 is necessary for normal
differentiation of 3T3-L1 cells and acts upstream of C/EBPβ and PPARƔ. Of note
however, the reduction of PPARƔ gene expression was not proportional to the
decrease in adipogenesis suggesting that KLF4 might partially promote the
differentiation of adipocytes independent of PPARƔ.
KLF4 transactivates C/EBPβ at a conserved -1.45kb to -1.1 kb region
of the C/EBPβ promoter
The data shown above suggested that KLF4 might regulate C/EBPβ
transcription. To test this hypothesis, a virus expressing a KLF4-HA-protein and
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a control plasmid were cotransfected into 293T cells with a promoter-luciferase
reporter plasmid (B3K), which contains 3kb of the C/EBPβ promoter(This
construct was generously provided by Daniel Lane). These showed that KLF4
transactivated the C/EBPβ promoter (B3K) by ~10 fold, in a dose dependent
manner (Figure 12A).

Figure 12 KLF4 transactivates the C/EBPβ promoter
A) Transactivation of C/EBPβ plasmid by KLF4
B) A deletion series derived from of a luciferase reporter construct (B3K), carrying 3kb promoter
region of C/EBPβ (generously provided by Daniel Lane) was cotransfected with 250ng of
pMSCV-KLF4 and pRL-TK(Renilla). Results were expressed as firefly luciferase activity
normalized for renilla luciferase activity.
C) CHIP analysis of KLF4 binding to the target region on C/EBPβ promoter. 3T3-L1 cells were
fixed 2.5h post-differentiation and chromatin samples were subjected to CHIP assays by using a
KLF4 antibody or normal rabbit IgG as a control. An upstream region (-2.5kb) in C/EBPβ
promoter was also checked as negative control.
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To further narrow down the region(s) responsible for the transactivation of
KLF4, a series of 5' deletions of the C/EBPβ promoter was generated and
analyzed for the induction in response to KLF4. Transactivation by KLF4 dropped
by more than 5 fold, when a region from -1.45kb to -1.1kb was deleted (Figure
12B). Deletion of sequences from -3kb to -1.5kb region resulted in a further 2-fold
decrease in the activation.
To assess whether KLF4 directly activated the C/EBPβ gene, I next
assayed the binding of KLF4 to the endogenous C/EBPβ promoter in 3T3-L1
cells using chromatin immunoprecipitation assays 3T3-L1 cells were differentiated
for 2.5 hours at which time DNA-protein complexes were cross-linked and CHIP
assay was performed by using an anti-KLF4 antibody, or rabbit IgG as a control.
Chromatin precipitation using the anti-KLF4 antibody caused a significant
enrichment of the C/EBPβ promoter sequence indicating that the KLF4
transcription factor is directly bound to the C/EBPβ promoter (Figure 12C).
Further characterization of the region between -1.45 to – 1.1 kb of the C/EBPβ
promoter was performed using gel shift assays with fragments of the promoter
and bacterially expressed Klf4. Seven 55bp oligos spanning the 1.45kb-1.1kb
region were incubated with recombinant GST-KLF4 protein. GST-KLF4 shifted 3
of these oligos and this was correlated with the results of a cotransfection of Klf4
with a series of C/EBPΒ promoter deletions between -1.45 to – 1.1 kb. (Figure
13) Same binding could not be seen by Krox20. Taken together, these findings
suggest that KLF4 transactivates C/EBPβ gene by binding directly to several
sites on 1.45kb-1.1kb region of the promoter. However the sequences of these
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oligonucleotides were different and DNAse footprinting failed to reveal a clear
consensus sequence (data not shown). This suggests that the Klf4 binding site
may be highly degenerate.

Figure 13: KLF4 binds C/EBPβ promoter
Gel shift assay with 293T nuclear extracts overexpressing KLF4 (C) or purified GST-KLF4 (A)
Seven 55bp oligos spanning the 1.45kb-1.1kb region were checked for their ability to bind to
nuclear extracts or recombinant GST-KLF4 protein. B) A deletion series between 1.45-1.1 kb
fragment derived from of a luciferase reporter construct (B3K) was cotransfected with 250ng of
pMSCV-KLF4 and pRL-TK (Renilla). Results were expressed as firefly luciferase activity
normalized for renilla luciferase activity.
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KLF4 and Krox20 interact and transactivate the same site of the
C/EBPβ promoter
Krox20 transactivates the C/EBPβ promoter via sequences between
1.45kb-1.1kb which is identical to that reported above for Klf4 (Figure 14B). The
fact that KLF4 and Krox20 also have similar expression kinetics led us to
examine whether the ability of these transcription factors to activate C/EBPβ
promoter is synergistic. Plasmids directing the expression of Krox20 and KLF4
were co-transfected into 293T cells using the same C/EBPβ promoter-luciferase
reporter.

Transfection of KLF4 or Krox20 alone led to a 6-fold and 4-fold

induction respectively, while simultaneous transfection of both plasmids
increased the luciferase activity 10-fold (Figure 14C).
Since Krox20 (Chen et al., 2005a) and KLF4 bind to the same region and
can both activate transcription of C/EBPβ, I considered the possibility that these
proteins might bind to one another. Flag-tagged KLF4 and HA-tagged Krox20
were ectopically expressed in 293T cells for 2 days and the lysate was
immunoprecipitated using anti-FLAG M2 agarose beads (Sigma), washed
extensively with BA300 (300mM NaCI) and immunoblotted using an ant-HA
antibody. In this assay, immunoprecipitation of KLF4 using an antibody to the
Flag tag pulled down Krox20 (Figure 15). In addition studies using standard
mammalian 2-hybrid assay provided functional evidence that Krox20 and Klf4
can bind to one another and activate gene expression (data not shown).

A

cross-species comparison of the C/EBPβ promoter further indicated that the

49

1.45kb-1.1kb region is the only region that is significantly conserved among
mammals (Figure 14C).

Figure 14: Effect Krox20 and KLF4 on C/EBPβ promoter
A) KLF4 and Krox20 expression plasmids were cotransfected with the C/EBPβ luciferase reporter
construct. An additive effect for transactivating C/EBPβ promoter was shown.
B) A deletion series derived from of a luciferase reporter construct (B3K), carrying 3kb promoter
region of C/EBPβ (generously provided by Daniel Lane) was cotransfected with 250ng of
pMSCV-Krox20 and pRL-TK (Renilla). Results were expressed as firefly luciferase activity
normalized for renilla luciferase activity.
C) Conservation in 1.45-1.1 kb promoter region of C/EBPβ gene (UCSC genome browser)
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Figure 15: Interaction of KLF4 and Krox20
A) Coimmunoprecipitation of KLF4 with Krox20. FLAG-KLF4 and Krox20-HA were cotransfected
into 293T cells. After 2 days, cells were lysed and co-immunoprecipitated using an anti-FLAG
antibody and immunoblotted against HA. The data shows the specific binding of KLF4 to Krox20.
B) GST pull-down assays. Krox20 and luciferase plasmids were in vitro translated in presence of
S35, mixed with purified GST-KLF4 and pulled-down by GST beads. Krox20 but not luciferase
was pulled down by GST-KLF4.
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Krox20

and

C/EBPβ

overexpression

partially

overcomes

the

knockdown of KLF4
The data suggested that Klf4 acted upstream of C/EBPβ. If true,
expectation would be that overexpression of C/EBPβ or Krox20 should bypass
the effect of KLF4 knockdown. To test this, 3T3-L1 cells were infected with
retroviruses carrying KLF4 siRNAs and either Krox20-HA or C/EBPβ. These data
confirmed that the negative effect of a KLF4 knockdown on adipogenesis can be
ameliorated by the overexpression of either Krox20 or C/EBPβ as assessed
using Oil red O staining and measuring the level of expression of aP2, adipsin
and PPARƔ2 (Figure 16).
KLF4 expression is dependent on IBMX but not on Dexamethasone
or Insulin
These data show that KLF4 and Krox 20 cooperate to activate C/EBPβ
transcription and establish them as among the earliest if not the earliest factors
induced during adipogenesis. If this is true, both factors might be expected to
respond directly to one of the components of the adipogenic cocktail and not the
others. To test this, confluent 3T3 cells were exposed individually to each of the
three components of the induction cocktail: insulin, dexamethasone, and the
phosphodiesterase inhibitor IBMX. Insulin and dexamethasone concentrations
did not change KLF4 levels at 2 hr post-induction, the time at which KLF4 is
maximally induced in response to the three-component cocktail. On the other
hand, IBMX increased KLF4 levels 4 to 5 fold (Figure 17) and increasing

52

concentrations of IBMX proportionally increased C/EBPβ and KLF4 gene
expression (Figure 17B).

Figure 16 Krox20 and C/EBPβ overexpression partially overcomes the knockdown of KLF4
3T3-L1 cells were coinfected with pMSCVhyg-derived retroviruses carrying either Krox20-HA/
C/EBPβ or control insert and pSIREN-RetroQ-derived retroviruses carrying either siRNA oligos
for KLF4 or control oligo, selected for hygromycin and puromycin resistance, and induced to
differentiate till day 7.
A) Overexpression of Krox20 overcomes the knockdown of KLF4. Upper panel shows the oil red
O staining and lower panel shows the TAQMAN analysis of 3 late genes, aP2, adipsin and
PPARƔ2.
B) Overexpression of C/EBPβ overcomes the knockdown of KLF4. Upper panel shows the oil red
O staining and lower panel shows the TAQMAN analysis of 3 late genes, aP2, adipsin and
PPARƔ2.
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To further assess the effect of IBMX on KLF4 in 3T3-L1 cells, 293T cells
were transfected with a luciferase reporter driven by 2 kb KLF4 promoter. When
the transfected cells were exposed to IBMX, 3 to 4 fold increase in luciferase
activity was observed (Figure 17C).
KLF4 and Krox20 are regulated through a negative feedback loop
Overall these data suggest that KLF4, Krox 20 and C/EBPβ compose a
network of transcription factors that play a key role in orchestrating the early
events of adipogenesis. The interaction among these factors was checked by
analyzing their expression in cells in which only one of these transcription factors
was knocked down by stable expression of their corresponding siRNA.

The

C/EBPβ knockdown cell lines showed a robust 2 fold increase in Krox20 and
KLF4 expression levels at 2 hours post-induction, suggesting that C/EBPβ
expression normally inhibits its upstream activators via a negative feedback
mechanism. These data add further evidence that it is a downstream target of
KLF4 and Krox20 (Figure 18A).
Consistent with the hypothesis, a 3T3L1 cell line that over expressed
C/EBPβ showed a robust early decrease of KLF4, and to a lesser extent in
Krox20 expression levels (Figure 18B). A negative effect of C/EBPβ on KLF4
expression was also seen using the KFL4-luciferase reporter. Co-expression of
the KLF4-luciferase reporter with C/EBPβ in 293T cells reduced KLF4 expression
as much as 30% and was dose-dependent.

This inhibition was even more

robust, i.e.; 70%, when these cells are incubated with IBMX (Figure 19).
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Figure 17 KLF4 expression is dependent on IBMX
A) Individual components of the induction cocktail (IBMX,dexamethasone and insulin) were
added onto confluent 3T3-L1 cells alone or in combination. Cells were harvested 2h posttreatment for Taqman analysis of KLF4. Panel shows the effect of each component on gene
expression. B) The left panel shows dose-dependent induction of KLF4 and C/EBPβ. Confluent
3T3-L1 cells were treated by increasing amounts of IBMX (0 to 0.5 mM). Cells were harvested
2h-post induction for Taqman Analysis.
C) IBMX can transactivate C/EBPβ promoter in 293T cells in vitro. 293T cells were transfected
with KLF4 luciferase reporter plasmid carrying 2kb upstream of KLF4 promoter. 16 hours later,
the cells were either treated with DMSO or 0.5mM IBMX for 8 hours. After treatment, cells were
harvested for luciferase assays.
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Figure 18: KLF4 and Krox20 are regulated by C/EBPβ through a negative feedback loop
3T3-L1 cells were infected with retroviruses expressing C/EBPβ knockdown or overexpression
constructs. Cells were selected, differentiated and the effect of C/EBPβ expression on KLF4 was
observed.
A) KLF4 and Krox20 levels are upregulated in C/EBPβ knockdown 3T3-L1 cells.
B) KLF4 and Krox20 levels are downregulated in C/EBPβ overexpressing 3T3-L1 cells

Overall, these results suggest a potential negative feedback mechanism
whereby C/EBPβ actively down-regulates its upstream regulators and add further
evidence to the possibility that KLF4 and Krox20 act upstream of C/EBPβ.
Overall, these data indicate that the level of expression of Klf4 is tightly
controlled, a finding that is consistent with the observation the overexpression of
Klf4 leads to cell cycle arrest in preadipocytes (and other cell types) further
suggesting that Klf4 must be expressed at tightly regulated levels in a narrow
window during adipogenesis.
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p300 co-activates KLF4/Krox20 dependent C/EBPβ expression
In order to assess the effect of possible coactivators of this early
regulatory network, several co-activators including GRIP-1, SRC-1,TRAP220 and
p300 were cotransfected along with KLF4, Krox20 and both. This experiment
showed that p300 has the most co-activation potential in this context (Figure 20).

Figure 19: KLF4 transcription is inhibited by C/EBPβ.
293T cells were cotransfected with increasing amounts of C/EBPβ plasmid along with a luciferase
reporter plasmid carrying 2kb promoter of KLF4. After 16 hours the cells were treated with DMSO
or 0.5mM IBMX. Cells were harvested after 8 hours for luciferase assays.

Leptin treatment down-regulates early genes including KLF4 in the
preadipocyte fraction
Leptin treatment of ob/ob mice reduces food intake and body mass, and
has been suggested to decrease adipogenesis particularly in ob mice compared
to PBS treated controls. Fat tissue from 12-day leptin or PBS treated ob animals
was isolated and RNA was prepared from the preadpocyte fraction.
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The

expression levels of KLF4, Krox20, C/EBPβ and C/EBPβ were measured using
specific TAQMAN assays.

All of these early genes were downregulated by

approximately 2-fold in the preadipocyte fraction in 12 day leptin treated animals
compared to 12d PBS treated animals (Figure 21).

Figure 20: p300 is the predominant coactivator of KLF4 in vitro.
The KLF4 and Krox20 plasmids were transfected into 293T cells along with the luciferase reporter
carrying 3kb C/EBPβ promoter and a series of coactivators. Results were normalized by Renilla
Luciferase.

Discussion
Adipogenesis is controlled by a cascade of transcription factors that act to
induce the expression of gene products necessary for the acquisition of the
characteristic morphology and specialized functions of adipocytes (Farmer,
2006a). Previously C/EBPβ has been shown to be among the first transcription
factors activated during adipogenesis and it is considered to be one of the
initiators of a transcriptional cascade, which in turn activates C/EBPβ and
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PPARƔ2 (Rosen et al., 2002). These latter genes then activate the genes that
mark the fully differentiated adipocyte phenotype. However, the upstream factors
regulating C/EBPβ expression have not been characterized.

Figure 21: Leptin treatment reduces expression of early genes in stromavascular fraction.
6 ob/ob animals were treated with leptin or PBS. Animals were sacrificed after 12 days leptin/PBS
treatment and stromavascular fraction was collected for Taqman assay.

KLF4 gene expression is induced early during adipogenesis in response
to IBMX, one of the components of the standard induction cocktail. KLF4
knockdown cell lines showed a marked decrease in adipogenesis as assessed
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using Oil Red O and reduced expression of differentiated fat markers such as
aP2, adipsin and PPARƔ2. However, the decrease in PPARƔ2 expression
seems to be less prominent than for the other two markers suggesting that Klf4
might have PPARƔ2-independent effects. KLF4 knock-down cells also showed
reduced expression of C/EBPβ, adding functional evidence to support the
conclusion that KLF4 is upstream factor of C/EBPβ in the transcriptional network
controlling adipogenesis. Consistent with this, KLF4 is able to transactivate a
luciferase reporter driven by 3kb C/EBPβ promoter in a dose dependent manner,
and a deletion series further localized the critical region to between−1438 and
−1134 base pairs. CHIP assays and gel shift assays confirmed the binding of
KLF4 to C/EBPβ promoter at this conserved critical region. KLF4 seems to bind
several sites along this region as assessed by footprinting studies.

The

extensive homology of this region of the C/EBPβ promoter suggests that these
promoter sequences are functionally important. Note that, Krox20 could not be
shown to bind C/EBPβ promoter in both Chromatin IP assays and gel shift
assays. This suggests that Krox20 may be acting on C/EBPβ promoter through
KLF4. It is also possible that Krox20 binding to C/EBPβ promoter requires an
interaction with other unidentified partners.
Krox20 has previously been shown to activate C/EBPβ promoter in the
same promoter region (Chen et al., 2005a). Klf4 and Krox20 trans-activation is
additive with KLF4, suggesting that both factors cooperate to activate C/EBPβ
expression in adipogenesis. In addition, overexpression of either Krox20 or
C/EBPβ seems to bypass KLF4 knockdown phenotype, further supporting the
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role of Krox20 and KLF4 to activate C/EBPβ. It was also shown that, in
cooperation with p300 these two factors potently transactivate C/EBPβ promoter.
Consistent with this, ribozyme-mediated targeting of p300/CBP suppresses
differentiation of 3T3-L1 preadipocytes into adipocytes, indicating that p300 is
also necessary for adipogenesis (Takahashi et al., 2002).

p300 has been

previously shown to interact directly with KLF4 by using pull-down assays
(Feinberg et al., 2005). These data suggest that p300 might play a role in early
phases of adipogenesis via interactions with Krox20 and KLF4 potentially with
other proteins to form a protein complex that induces C/EBPβ and coordinates
some (though not all, see below) of the key early events during adipogenesis.

Figure 22: Early transcriptional network in adipogenesis
KLF4, Krox20 and possibly p300 are a part of early transcriptional network acting on the early
master regulator of adipogenesis, C/EBPβ. C/EBPβ, then, activates PPARƔ, leading to the
transcription of adipogenic genes.
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A knockdown of C/EBPβ increases the expression of KLF4 and the
overexpression of C/EBPβ reduces KLF4 expression. These data indicate that
C/EBPβ acts downstream of KLF4 and reduces its expression by feedback
inhibition. Ectopic expression of KLF4 results in cell-cycle arrest in several cell
lines including NIH3T3 cells and its transcriptional targets are involved in
differentiation and cell-cycle inhibition (Chen et al., 2001; Chen et al., 2003;
Shields et al., 1996). Consistent with this, over-expression of KLF4 in 3T3L1
cells leads to slow proliferation even before differentiation and these cells
differentiate extremely poorly (data not shown). These results also suggest that
the levels of KLF4 must be tightly controlled either quantitatively and/or
temporally.
KLF4 is specifically activated by IBMX, an inducer of cAMP, but not by
dexamethosone or insulin, the other two components of the adipgenic cocktail.
IBMX by itself can partially induce adipocyte differentiation in 3T3L1 cells in vitro
but IBMX treatment does not fully recapitulate the effects of the entire cocktail
(Yeh et al., 1995). This suggests that other factors activated by dexamethosone
and insulin, in combination with KLF4, are necessary for the activation of the fully
differentiated adipocyte phenotype.
It is not known whether the failure of IBMX to fully activate adipogenesis is
the result of a failure to fully induce the quantitative expression of downstream
mediators such as C/EBPs or if additional, as yet unidentified factors are
required. The identification of these dexamethosone and insulin induced target
genes would resolve this issue and advance our understanding of the earliest
62

events of adipogenesis.

It is not known however whether KLF induction by

cAMP is a direct effect via PKA phosphorylation of CREB family transcription
factors or if another mechanism contributes (Reusch et al., 2000a; Zhang et al.,
2004a).

The fact that CREB phosphorylation is required for early events in

adipogenesis is consistent with this possibility (Reusch et al., 2000a). However,
cotransfection of CREB with a KLF4-promoter-luciferase reporter construct in the
presence of forskolin, did not show any increase in KLF4 expression (data not
shown) suggesting that the effect of CREB on Klf4 expression is likely to be
indirect.
The role of KLF4 in vivo could be further tested in fat specific knockouts of
KLF4 however the interpretation of such data could be complicated by the fact
that the expression of KLF4 might not be required at later times in adipogenesis
such as when the aP2 promoter is turned such as in aP2-cre or leptin-cre mice
(unpublished data) (Jones et al., 2005a).

In other words, an aP2 directed

knockout of KLF4 would not be informative, if KLF4 is not required for the
maintenance of adipose tissue. The low levels of KLF4 in fully differentiated
adipocytes are consistent with this possibility. Thus promoters that direct cre
expression early in adipogenesis i.e. in preadipocytes is likely to be required to
assess the inductive role of KLF4 in tissue specific knockouts. Because such
promoters are not known or available, the delineation of a role for KLF4 in vivo
might require an ES cell complementation strategy analogous to that recently
developed to study pancreatic development (Stanger et al., 2007).
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In summary, KLF4, here, is identified as an essential player in adipocyte
differentiation (Figure 22). These findings put KLF4 among a group of key
proadipogenic early transcription factors, including Krox20 and CREB (Reusch et
al., 2000a; Zhang et al., 2004a). It seems that there is an earlier transcriptional
regulatory network before C/EBPβ expression at least in vitro.
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CHAPTER 4:
Characterization of Adipogenesis in vivo
Introduction:
Obesity can be a result of both hypertrophy, an increase in adipocyte size,
and hyperplasia, an increase in cell number. In the previous section, an early
adipogenic transcriptional network including Krox20, Klf4 and C/EBPβ was
identified. However, those experiments were limited to the in vitro adipogenic
processes (Fischbach et al., 2004) (Mandrup et al., 1997a). Unfortunately, the
information regarding in vivo adipogenesis is very limited. On the way to study
adipogenesis in vivo, a major issue is identifying the progenitor cells that make
up the fat cells in adipose tissue.

Figure 23 Scheme for identification of adipocyte progenitor cells
SVF fraction is sorted based on several surface markers and injected in a conducive
hyperadipogenic environment for growth. Cells can be tracked using an in vivo imaging assay
without killing the animal.

An experimental scheme for identifying the adipocyte progenitor fraction is
as follows. Firstly, stromavascular fraction can be sorted using various cell
65

markers by fluorescence-activated cell sorting (FACS). Next, these cells can be
transplanted into an in vivo model, preferably with a conducive adipogenic
environment. Lastly, there is a need to monitor the growth of adipocytes from
these cells (Figure 23). This scheme is analogous to previous assays employing
precursor cell transplantation in vivo for the study of hematopoietic, mammary
epithelial, and spermatogonial stem cells (Brinster and Zimmermann, 1994;
Deome et al., 1959; Ford et al., 1956).
Results
A Lipodystrohic Model contains hyper-adipogenic/proliferative fat
pads
Lipodystrophy is a medical condition characterized by complete loss of fat
depots and usually associated with hepatomegaly, hyperglycemia, insulin
resistance, hyperlipidemia and hypermetabolism (Chinen, 2001; Hegele, 2000).
One model of genetic lipodystrophy in rodents is A-ZIP lipodystrophic mouse
model.

A-Zip lipodystrophic mice have a severe, generalized lack of WAT

(Moitra et al., 1998), and retain very small WAT depots at the sites where mature
WAT depots typically develop in wild type animals (Figure 24). These mice
express a dominant-negative transcription factor (A-Zip) that inhibits C/EBP
transcription factors under the control of the aP2 (FABP4) promoter (Moitra et al.,
1998). The transgene encodes a peptide, carrying an acidic portion, which binds
to the B-ZIP leucine zipper transcription factors stronger than their corresponding
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DNA binding site. Thus, this dominant negative peptide blocks the DNA binding
of B-ZIP transcription factors such as C/EBPs.

Figure 24 A-ZIP lipodystrophic animals
A) Depiction of the dominant negative transgene of A-ZIP animals. Dominant negative peptide
carries an acidic extension which binds to C/EBP factors with high affinity, preventing their
binding to DNA. B) Overall morphology of lipodystrophic animals. The animal on the right side is
lipodystrophic. Note the lack of any visible fat. C) Ventral view of the lower abdomen of female
littermate wild-type (WT) and A-Zip mice at 12 weeks of age. The bladder (bl), uterus and
fallopian tubes (ut), and parametrial WAT (adi) are indicated

Since aP2 is expressed relatively late in adipogenesis it was reasoned
that there might be an expansion of precursor cells upstream of this block in
differentiation caused by the expression of the transgene. It was also possible
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that by blocking C/EBP and downstream factors, the negative feedback loop that
inhibits KLF4 and Krox20 will not work, resulting in induction of these genes.

Figure 25: Early genes are upregulated in A-ZIP remnant adipose organ
A) Taqman RT-PCR was performed for the markers of early adipogenesis, Krox20, Klf4, and
Cebpδ, as well as PPARƔ. RNA was isolated from adult A-Zip and WT parametrial adipose
*
**
tissue. Results are shown as mean ± SEM, n = 3 ( , p < 0.05; , p < 0.001). B) Immunostaining of
parametrial WAT from A-Zip and WT mice for the early markers of adipogenesis Krox20, Klf4,
and phospho-CREB, as well as the proliferation marker BrdU, is shown. For BrdU incorporation
analysis, mice were treated with BrdU for 7 days prior to immunostaining.

As explained above, it was hypothesized that inhibition of the formation of
mature adipocytes in the WAT depots of the A-Zip animals would lead to an
increase of proliferation and differentiation of precursor cells upstream of the
block in differentiation. If true, cells in the stromal fraction of these depots should
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continue to express genes induced early during adipogenesis (upstream of the
block induced by the transgene) and continually proliferate in a manner similar to
the clonal expansion phase of adipogenesis in preadipocyte cells lines induced to
differentiate in vitro. To test this, expression of genes typically induced early
during adipogenesis were analyzed in the A-Zip WAT depots. It was found that
RNAs for early markers of adipogenesis, Klf4, Krox20 and C/EBPδ, were
increased in A-Zip WAT depots relative to wild type WAT by 191%, 498% and
291%, respectively, while the expression of PPARγ, a marker of mature
adipocytes, was decreased to 56% of the levels in wild type tissue (Figure 25A).
Consistent with this, immunohistochemistry for Krox20 and Klf4 indicated very
low expression of these factors at the protein level in wild type WAT with a
significant increase in the numbers of Klf4 and Krox20 positive cells in A-Zip
WAT (Figure 25B). In lipodystrophic WAT, there was also a similar increase in
the level of CREB phosphorylation, one of the earliest events observed during
adipogenesis in vitro (Zhang et al., 2004a) (Figure 25B).
Above data suggests that A-ZIP adipose is hyperadipogenic. Since
preadipocytes proliferate through clonal expansion in vitro, proliferation was
tested in lipodystrophic WAT. Briefly, A-Zip mice were treated with BrdU for
seven days and fat tissue sections were analyzed by immunohistochemistry.
Analysis of BrdU incorporation showed that A-Zip adipose tissue contains large
numbers of proliferating cells compared to wild type adipose in which there are
barely detectable levels of BrdU incorporation, as expected due to its quiescent
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state (Figure 25B). The percent of BrdU positive cells was significantly higher in
lipodystrophic fat pads compared to wild type fat pads (Data not shown).
These

results,

all

together,

suggest that A/ZIP mice can provide a
conducive environment for the injection of
candidate progenitor cell fractions, due to
its

hyperadipogenic/hyperproliferative

environment.
A luciferase transgenic model
to study adipogenesis in vivo
In order to follow the fate of
adipose tissue under different conditions,
Figure 26: Leptin-luciferase BAC
transgenic animals
Luciferase activity in tissues (A) and
fractionated WAT isolated from leptinluciferase mice.(C) Luciferase can also be
detected in the animals, using a CCD
camera.(B) The indicated tissues were
isolated, and luciferase activity was
determined. Data shown are normalized to
total protein in each lysate. Results are
***
shown as mean ± SEM; , p < 0.001 (n =
3).

a transgenic animal, in which luciferase is
expressed under the control of leptin
gene

regulatory

sequences,

was

generated. Leptin is highly enriched in
adipose tissue and luciferase was chosen
as the reporter since it can be quantified
in vitro biochemically and in vivo by

imaging anesthetized animals using a CCD camera. In vivo imaging allows one
to monitor luciferase levels in the same animal over time, without having to
sacrifice animals.
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Leptin-luciferase transgenic animals were generated using BAC number
RP24-69D4 from UCSC database. This BAC contains 22 kb of 5' sequence and
160 kb of 3' sequence relative to the
leptin transcription start site. The firefly
luciferase-polyA (Promega) was inserted
into the ATG site of the leptin BAC via
homologous

recombination

and

transgenic mice were generated by
pronuclear injection of the modified BAC.
All subsequent studies use the D7-1 line,
which has nine copies of the modified
BAC incorporated as determined by real
time PCR analysis (data not shown);
similar data were obtained for the other
Figure 27: Luciferase regulation
recapitulates leptin regulation in leptinluciferase animals
Luciferase activity recapitulates regulation of
leptin. The relative expression of luciferase
versus leptin was compared among fed,
fasted, and ob/ob animals. (Lower)
Endogenous leptin expression levels from
fasted, fed, and ob/ob animals were
measured by Taqman real time PCR
normalized to cyclophilin levels. (Upper)
Luciferase activity of adipose tissue lysates
from fed, fasted, and ob/ob animals
normalized to protein content (mean ±
SEM).

line.
Tissue

specific

expression

of

luciferase in leptin-luciferase transgenic
animals

was

confirmed

using

biochemical assays from lysed tissues
and in vivo imaging. Luciferase activity,
normalized to the amount of total protein,
was present specifically in adipose tissue

at high levels with undetectable levels in other tissues, other than intestine
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(Figure 26A and B). It is not clear if the small signal of luciferase expressed in
this tissue is in epithelial cells or in resident adipocytes.

Figure 28: Regulation of luciferase upon high fat feeding in leptin-luciferase animals
Luciferase and leptin mRNA levels of leptin-luciferse animals fed on a high-fat diet versus normal
diet. (Upper Panel) Animal-to-animal comparisons of leptin mRNA versus luciferase levels in high
fat treated animals (Lower Panel)
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To confirm that the leptin-luciferase transgene was correctly regulated
quantitatively, it was next tested whether luciferase expression was correlated
with leptin mRNA levels in obese and lean animals. Leptin levels are highly
correlated with cellular lipid content and its mRNA levels can vary hundreds of
fold among fasted vs. obese animals (Maffei et al., 1995a). Relative expression
of luciferase vs. leptin was compared among fed, fasted and ob/ob visceral fat
pads. There was a hundred fold greater level of luciferase activity in extracts from
ob/ob adipose tissue vs. extracts from fasted animals, which fully recapitulated
the mRNA levels for endogenous leptin expression (Figure 27). These results
were also confirmed in vivo using a CCD camera to monitor luciferase activity.
(see Regulation of leptin gene expression chapter) Another evidence for
correlation between luciferase levels and leptin mRNA levels came from high-fat
feeding experiments. Fold induction of leptin gene expression in high-fat fed
leptin-luciferase animals versus chow-diet fed animals was highly similar to that
of luciferase levels. In addition, leptin mRNA correlated tightly with luciferase
levels within subjects, ie. fatter animals having higher luciferase levels (Figure
28). Same fold inductions have been observed also in luciferase mRNA levels,
which suggest that luciferase expression in the leptin-luciferase mice depends
mostly upon transcriptional regulation (Data not shown).
It should be noted that SVF fraction does not express leptin.
Preadipocytes express leptin when differentiated to adipocytes. For this reason,
use of leptin-luciferase animals provides a robust tool to track possible adipocyte
progenitor cells and differentiation ability into mature adipocytes. Since leptin
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correlates very well with the amount of lipid stored, the signal increases over time
as the differentiated adipocyte accumulate more and more lipid (Figure 26C).
Isolation of adipocyte progenitor cell using markers
WAT is composed of multiple cell types including adipocytes, vascular
cells and populations of fibroblast like cells that
have not been well characterized (Cinti, 2005).
To identify potential adipocyte progenitor cells,
the stromal-vascular fraction (SVF) of wild type
WAT was isolated (Rodbell, 1964) and FACS
was performed to isolate distinct cell populations
based on the differential expression of well
characterized cell surface markers expressed by
stem cell populations in other tissues. The cell
sorting strategy that was used in these studies is
shown (Figure 29) and described below. Briefly
lineage markers (Lin) and CD34, CD24 and Sca1
are used to isolate the progenitor cell fractions.
Among these markers, CD34 was previously

Figure 29: Scheme for FACS
analysis of SV fraction
The scheme for the FACS
analysis is shown as a
dendrogram of the hierarchy
developed for cell sorting. The
percentage yield of each
population compared to the
starting number live single cells
derived from the SVF is indicated.

suggested to be enriched in adipocyte progenitor
cells (Miranville et al., 2004). CD24 and Sca1 were both implicated to have roles
in stem cell biology as shown by previous studies (Lian et al., 2007; Okada et al.,
1992; Rao et al., 1995; van de Rijn et al., 1989).
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The FACS strategy was used to enrich for adipocyte precursors that were
fully competent for adipogenesis in vitro. First, endothelial cells and
hematopoietic cells were depleted from the SVF based on staining of CD31,
CD45, and Ter119, generating a Lineage negative (Lin-) population. Second, the
cell populations depleted of the lineage markers were separated based on
staining for CD34 and CD29, as described above. The Lin-:CD34+:CD29+
subpopulation was further separated based on staining for stem cell antigen 1
(Sca-1) and CD24 (Shackleton et al., 2006; Spangrude et al., 1988; Wilson et al.,
2007).

Figure 30: In vitro differentiation of adipocyte progenitor fractions
+

−

−

The sorted CD24 , CD24 , and CD34 cells and unsorted SVF were cultured and induced to
differentiate with IBMX, glucocorticoid, and insulin. The cells were then cultured for 12 days prior
to staining with oil red O. Macroscopic (upper panel) and microscopic (lower panel) views of the
oil red O-stained dishes are shown (upper panel).

The Lin-:CD29+:CD34+:Sca-1+ population comprises approximately half
of the cells present in the SVF (53.5%), but only a small population of cells also
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expressed CD24 with the total number of Lin-:CD29+:CD34+:Sca-1+:CD24+
(CD24+) cells constituting in total ~0.08% of the cells in the SVF (Figure 29).
As the first step, these cell populations were tested based on their
differentiation ability in vitro. CD24+, Lin-:CD29+:CD34+:Sca-1+:CD24- (CD24-)
and Lin-:CD29+:CD34- (CD34-) subpopulations can differentiate into adipocytes
in vitro using the standard protocol. After exposure to an adipogenic cocktail in
vitro both populations, CD24+ and CD24-, developed into adipocytes with large,
unilocular lipid droplets that stain with Oil Red O (Figure 30). Similar
differentiation levels were found for both the CD24+ and CD24- subpopulations
when insulin alone was used for in vitro differentiation (Data not shown). Note
that while both CD24- and CD24+ populations could differentiate into adipocytes,
the CD34- cells did not differentiate in vitro. These data showed that the FACS
strategy that was employed had indeed enriched for adipocyte precursor cells.
In vivo adipogenic ability of different SVF fractions
Previous data suggested that the adipose tissue of lipodystrophic animals
may provide a microenvironment that is conducive to support the proliferation
and survival of preadipogenic cells. Furthermore, leptin-luciferase animals
provides the tool to monitor the ability of the CD24+ cells to develop into
adipocytes, since the expression of luciferase in these mice is restricted to
mature adipocytes within adipose tissue. Luciferase activity can be followed
noninvasively in vivo by imaging with a CCD camera. Since cells of the SVF do
not express the luciferase reporter, transplant of donor cells from the leptin76

luciferase BAC transgenic mice allows to follow the development of mature
adipocytes (as marked by luciferase activity) from the donor cells noninvasively
in vivo.

Figure 31: CD24+ cells reconstitute adipose tissue in lipodystrophic animals
Luciferase imaging of adipocyte differentiation in the A-Zip transplantation model at indicated time
+
−
−
points after injection of 50,000 donor cells from the CD24 , CD24 , or CD34 cell populations.

SVF cells from leptin-luciferase mice were isolated, FACS sorted and
injected in the fat depots of A-Zip mice. Mice injected with the CD24+ cell
population derived from leptin-luciferase animals expressed luciferase in the
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injected depot beginning at 2 weeks after injection with the expression of
luciferase gradually increasing through the end of the 12 week time course. In
contrast, injection of other cells did not yield high luciferase expression levels.
This result suggested that the CD24− subpopulation is capable of adipogenesis in
vivo but that the differentiation or proliferative potential of these cells is limited
(Figure 31).

Figure 32: Injection of CD24+ fraction corrects hyperglycemia and hyperinsulinemia in
lipodystrophic animals
+

−

−

A) Plasma (glucose) from A-Zip mice injected with the CD24 , CD24 , CD34 , or SVF cells, as
well as WT and A-Zip controls. Results are shown as mean ± SEM. Correction of blood glucose
+
by the CD24 population is significant (p < 0.05) at week 2 and remains significant through the 12
week experimental endpoint (n = 5). Results are shown as mean ± SEM.
+

B) The plasma (insulin) at the 12-week endpoint of A-Zip mice that were injected with the CD24 ,
−
−
CD24 , or CD34 cell populations and noninjected wild-type and A-Zip controls is shown. Results
*
are shown as mean ± SEM; , p < 0.05 (n = 5).
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A-ZIP

lipodystrophic animals

are extremely hyperinsulinemic

and

hyperglycemic, which can be ameliorated by leptin treatment or adipose
transplantation. If the cells are differentiating into functional adipocytes, the
expectation would be that CD24+ injected animals will show amelioration of high
glucose and insulin levels. For this reason, plasma glucose and insulin levels in
A-Zip mice injected with the CD24+, CD24−, or CD34− cell populations were
compared to noninjected A-Zip and wild-type control animals. Blood glucose was
normalized after injection of the CD24+ population into the A-Zip animals in those
animals where an adipose depot had formed. None of the other cell populations
showed this capacity (Figure 32). The decrease of blood glucose levels was
significant within 2 weeks of injection and was sustained for 12 weeks. Plasma
insulin levels also were normalized in these CD24+-injected animals (Figure 32).
These data indicate that the CD24+ cells generate functional WAT when injected
into the WAT depot of A-Zip mice.
Discussion
This section introduces a novel way of identification of the unknown
adipocyte progenitor cell population in vivo. Through FACS analysis, these
studies demonstrate that primary cells from the adipose tissue stromal fraction
can proliferate and differentiate into functional, mature adipocytes to reconstitute
a fully functional adipose depot in vivo, which is enough to ameliorate
lipodystrophic phenotype.
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One critical aspect of the study is the identification of A-Zip lipodystrophic
mice as hyperadipogenic/hyperproliferative model.

WAT of A-Zip animals

showed increased expression of early markers of adipocyte differentiation and
high rates of proliferation, suggesting that presumptive WAT provides a niche
conducive for promoting early events in adipogenesis. Indeed, CD24+ cells,
when injected into wild type adipose depots, do not give rise to new adipocytes,
which can be explained by the quiescence of the adult adipose depots (data not
shown) (Greenwood and Hirsch, 1974; Greenwood et al., 1974). In this regard,
A-ZIPs provide as the injection environment for identification of the CD24+
progenitor cells, making them a rare useful model for same type of studies.

Another important implication of this work is that CD24+ cells can produce
metabolically functional adipocytes, secreting the adipokines to ameliorate
lipodystrophic phenotype. It has previously been shown that the transplant of
normal adult WAT into A-Zip mice is required for correction of their insulin
resistance and hyperglycemia (Gavrilova et al., 2000). This also sets a
preliminary model for treatment of lipodystrophy. The same type of cells, if they
exist in humans, can be used as a stable source of fat cells in lipodystrophic
patients, providing a constant source of leptin and other adipokines.

The identification of an adipocyte precursor cell population provides a
means for identifying tissue factors in wild-type and lipodystrophic WAT that
regulate adipocyte proliferation and differentiation. Furthermore, the availability of
the leptin-luciferase mice as donors in the A-Zip transplant assay, which allows
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the noninvasive monitoring of adipogenesis in vivo, should facilitate the
identification of conditions that optimize engraftment of adipose tissue
precursors.
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CHAPTER 5:
Embryonic Development of Adipose Tissue
Up to this date, embryonic development of adipose tissue in rodents has
not been fully characterized. One caveat to study adipose tissue development is
that the adipocyte and lipid markers are thought to be expressed after the
accumulation of lipids. However, it is very likely that the adipocyte character and
commitment occurs before the accumulation of lipids. In this regard, lipid markers
cannot be used to localize where adipose tissue develops. In this section,
location of adipose tissue is determined using a leptin-luciferase transgenic
animal (Birsoy et al., 2008). Identification of location of the developing adipose
tissue helped to study the gene expression and morphology of these tissues.
Results
Location and Morphology
In order to study the embryonic development of adipose tissue, the first
step is finding the location of adipose tissue development. As explained above,
the location cannot be determined using lipid markers. In parallel, early markers
of adipogenesis usually have significant roles in other cell differentiation
processes, so commonly expressed in other places. For instance C/EBPs have
roles in hematopoiesis (Jones et al., 2002). Many KLF factors have roles in
epithelial cell differentiation (Katz et al., 2002; Swamynathan et al., 2007; Zheng
et al., 2009). In addition, there is almost no distinct morphology for “lipidless”
embryonic adipose to the naked eye.
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Figure 33: Embryonic development of adipose tissue
Leptin-luciferase animals were sacrificed at the indicated embryonic time points. Embryos were
imaged for assessing the location of possible adipose tissue structures.

The tool to study adipose tissue development came from a leptin
luciferase animal (see previous section) (Figure 26), where luciferase is
expressed in context of leptin regulatory sequences. Since leptin expression is
highly fat specific, any luciferase signal during embryogenesis is also thought to
be fat specific. Indeed, during development, luciferase signal can be detected in
leptin-luciferase mouse embryos (Figure 33). The signal is extremely low and the
animals should be exposed 10 minutes as opposed to 30 second exposure of an
adult leptin-luciferase animal. However, even this low level expression is enough
to detect the exact localization of the possible adipose tissue development sites.
Luciferase can be detected in E16.0 embryos and no E15.5 embryo showed any
detectable luciferase signal. The source of the luciferase signal emanates from
the subcutaneous areas as well as interscapular areas, consistent with the adult
adipose locations (Figure 33). One advantage of finding the locations of
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developing adipose tissue sites is that these sites can now be dissected and the
morphology and gene expression patterns be studied.
Microscopic analysis of AT development between E16.5-P0
Since the location of developing adipose tissue sites can be dissected,
next these small tissue fragments were analyzed by using whole-mount
technique under confocal microscopy. Vascularization, lipid accumulation and
overall morphology have been checked using different dyes as explained below.

Figure 34: Morphology of adipose tissue during development
Figure shows the fat accumulation and vascular structure of adipose tissue during development.
Tissues were dissected using dissection microscope. Green shows the vasculature, red shows
lipid and blue shows the nuclei staining. (A) Panel B shows the real time PCR analysis of leptin
through embryonic development. Note that the lipid accumulation is very correlative with the
leptin expression. Also note that lipid starts to accumulate after birth.
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The results show that lipid accumulation does not happen until after birth.
Just after birth, lipid starts to accumulate very rapidly in the adipocytes as
assessed by lipid-tox staining at P0. Real-Time PCR analysis of leptin shows that
big increases for leptin expression occur rapidly after birth around P2-P5, which
is consistent with the fact that lipid accumulation is highly correlated with the
expression of leptin (Figure 34). In addition, note that, real time PCR analysis
shows extremely low leptin expression levels before birth, which suggests that
the CCD camera system is very sensitive to luciferase signal detection.
Gene expression analysis of adipose tissue development
Embryonic adipose tissue fragments can be dissected and analyzed as
explained above. As a part of the characterization, developing adipose fragments
were digested by collagenase and sorted in order to analyze the percentage of
different adipocyte populations. Of importance, P1 (CD24+,CD34+) population
showed significant change during development. Preliminary results show that this
population, which was identified to be the adipocyte progenitor cell population,
increases around E18.5 just before birth (data not shown).
Microarray analysis was also performed on the developing subcutaneus
adipose tissue. Figure 35 shows the change in early genes and late genes during
development of adipose tissue. Note that, compared to 3T3-L1 differentiation,
this data is in vivo and leptin expression can be detected at high levels.
Interestingly, late genes such as PPARƔ, CEBPa, FABP4, Adipsin and
Adiponectin were all found to be expressed at their maximum level around E18.5,
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before the start of lipid accumulation. On the other hand lipid accumulation
seems to be very consistent with the leptin expression levels (Figure 35). Early
genes such as KLF4, Pref1 and KLF5 are downregulated starting E16.5 to P0,
suggesting that early adipogenic processes along with the clonal expansion is
mostly completed before birth.

Figure 35: Gene Expression Analysis of Developmental Time course
Late genes such as PPARƔ, CEBPa, Adiponectin and Adipsin reach their maximum levels
around P0. On the other hand leptin levels plummet with lipid accumulation after birth. Many early
genes were found to be downregulated through development.

Discussion
In summary, above data provides the first thorough characterization of
embryonic development of adipose organ in rodents. This data suggests that in
vivo adipose tissue development may be different than in vitro adipocyte
differentiation in terms of genes and their temporal expression patterns.
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Figure 36: Distinct transcriptional networks regulating adipocyte differentiation in vivo

During development, luciferase signal can be detected in three major
locations;

posterior

subcutaneous,

anterior

subcutaneous

(neck)

and

interscapular region. Subcutaneous regions are consistent with the localization of
white adipose tissue in adults. However, interscapular signals suggest that these
signals may be coming from developing brown adipose tissue. One caveat of
identifying if the signal is coming from brown or white adipose tissue is that,
brown

adipose

tissue

contains

white

adipocytes.

Furthermore, interscapular region contains a separate white adipose tissue
located laterally to the brown adipose tissue. This suggests that close proximity
and heterogenous nature of brown fat may result in the luciferase signal in the
interscapular region. In addition, since leptin is a signal for energy stores, leptin’s
presence in brown adipocytes seem physiologically irrelevant. However, it is
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possible that brown adipocytes may express low amounts of leptin due to the
presence of lipid, as suggested by previous reports (Cinti et al., 1997; Oliver et
al., 2000).
Our data suggest that there are several distinct networks of genes that are
expressed during fat cell differentiation. One group includes the genes that are
upregulated during embryogenesis till the birth of the animal (Figure 36). This
group of genes contains adipocyte-related transcription factors such as PPARƔ,
C/EBPα and also secreted factors such as adiponectin and adipsin. The second
group of genes is upregulated with the accumulation of lipid. These genes
include leptin and other mostly uncharacterized genes. An important implication
of this analysis is that genes that are previously thought to be associated with the
adipocyte phenotype based on in vitro studies seem to be regulated
independently of the accumulation of lipid. On the other hand genes in the latter
cluster, including but not limited to leptin, are expressed correlative with the lipid
accumulation. Clustering analysis of genes in this microarray data may lead to
the identification of novel genes/pathways having roles in adipocyte function and
development in vivo.
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CHAPTER 6:
Regulation of Leptin gene expression
In mammals, homeostatic control of adipose tissue mass is regulated by
leptin, which functions as the afferent signal in a negative feedback loop to
maintain constancy of body fat content. Leptin is secreted in proportion to
adipose tissue mass and in turn
regulates

food

intake

and

energy

expenditure. A fuller understanding of
the elements of this system could have
important implications for the pathophysiology and treatment of obesity.
Figure 37: Amount of fat is sensed by
adipocytes.

Adipocytes secrete leptin in proportion
to their size meaning that as they

accumulate more lipids, they secrete more leptin (Figure 37). This suggests the
possibility that cellular lipid content is sensed and that a fuller understanding of
the mechanisms controlling leptin gene expression could lead to the delineation
of a lipid sensing mechanism in fat cells and possibly other cell types. To
discover this mechanism, there is need to search for the region in the leptin gene
promoter that controls the quantitative expression of the leptin gene; ie the
elements that confer increased leptin expression with obesity and decreased
expression after weight loss (see below). Since leptin is expressed at much
higher levels in fat tissue in vivo than in vitro where it is not regulated in
proportion to cellular lipid content, these studies require that gene expression be
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monitored in vivo. This part of the thesis deals with the regulation of leptin gene
expression via a BAC transgenics approach.
Results
Leptin expression can be studied using a BAC transgenic model
The leptin gene is relatively unusual because it is expressed at much
higher levels in vivo vs. in vitro in differentiated 3T3-L1 or F442 cells(Mandrup et
al., 1997b).

Since these cell lines abundantly express the master regulator

PPARƔ, CEBPs, and their targets, this suggests that the adipocyte specific
expression of leptin is controlled by a different transcriptional mechanism. Thus
the delineation of the basis for the tissue specific expression of the leptin gene
could reveal an in vivo specific developmental program. The fact that leptin is
only expressed at high levels in vivo has necessitated that the leptin promoter be
studied using transgenic mice. In order to confer all the regulatory regions, BAC
transgenic mouse lines that express luciferase under the control of overlapping
leptin regulatory sequences were generated.
Luciferase expression can be quantified in vitro as well as in vivo using a
CCD camera (Greer and Szalay, 2002b). Thus, DNA sequences responsible for
these regulatory processes can be generated by generating a series of promoter
deletions and then monitoring luciferase expression 1) in different tissues, 2) in
ob and fasted mice, 3) during development and 4) in response to hormones and
drugs. It should be noted that same DNA sequences may be responsible for
some or all of the different transcriptional responses the leptin gene exhibits.
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The net result of these studies will be to localize one or more DNA sites
responsible for conferring an ability of the leptin promoter to respond to intrinsic
and extrinsic signals.

Figure 38: Leptin gene structure

Leptin regulatory elements are in -22kb to -18kb region
Gene regulatory elements are often found at a great distance from
transcription initiation sites (Chandler et al., 2007; Choi and Engel, 1986a;
Murisier et al., 2006). For this reason and because there is no prior knowledge
of the sites of the gene regulatory elements that control leptin expression in vivo,
we began by making BAC transgenic mice in which the luciferase was inserted
into the second exon of the leptin gene at the site of the ATG initiation codon
(Figure 38A). Two overlapping BACs were modified in this manner using
homologous recombination in bacteria as previously described (Gong et al.,
2002). The first BAC extended from –22 to + 140 kB and the second extended
from –160 kB to + 18 kB (Figure 38B).
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Figure 39: -22kb - +18kb construct is enough for fat-tissue specificity and fat-sensing
regulation of leptin
Images on the left side show the luciferase activity of the corresponding leptin-luciferase BAC
transgenic line at different metabolic conditions. Each line was mated to ob animals to get obese
luciferase animals or fasted. Imaging was done using IVIS lumina CCD camera using ob, fed and
fasted mice.
Middle panel shows tissue expression of luciferase of the corresponding leptin-luciferase BAC
transgenic line. Briefly, each tissue was dissected and lyzed and luciferase activity was asssesed
using a luminometer.
Right panel shows the fat sensing regulation of the corresponding line upon fasting and obesity.
Fat tissue was dissected from 5 animals for fasted, obese and fed group and luciferase activity
was measured in fat using a luminometer, normalized by protein concentration. This result is
consistent with the imaging experiments. (Left Panel)

These BACs were injected into fertilized eggs from C57BL/6J mice and
founder mice were bred to generate F1 animals. The animals generated using
the BAC that extended from –22 to +140 kB were characterized first. Protein
extracts were made from a variety of tissues and analyzed for luciferase activity
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in the presence of luciferin the standard substrate. These studies showed very
high luciferase levels in adipose tissue with undetectable levels in the other
tissues that were tested. In this and subsequent experiments, the luciferase
activity was related to the amount of total protein (Figure 39).
The relative expression of luciferase vs. leptin was also compared among
fed, fasted and ob mice. The latter were made by mating the Leptin-Luciferase
BAC transgenes to ob/+ animals followed by intercrossing. In this case, there
was a several hundred fold greater level of leptin RNA and luciferase in the ob
vs. fasted animals (Figure 39).
The second set of transgenic animals made using the BAC that extended
from –160 kB to + 18 kB also gave the same results. These animals also show
fat specific luciferase expression with a marked decrease after fasting and a
marked increase when the animal is mated to ob/ob animals. Since both BACs
show coordinate regulation of leptin and luciferase over the same dynamic range
these data narrow the sequences required for fat specific and quantitative
regulation to between –22 kB and +18 kB of the gene. A -22kb-18kb animal was
also made to ascertain the region. Indeed this transgenic animal showed
consistent results with the previous animals (Figure 39).
Luciferase can also be quantified in vivo by imaging anesthetized animals
using a CCD camera(Greer and Szalay, 2002a; Welsh and Kay, 2005). In vivo
imaging allows one to follow luciferase levels in the same animal over time
(without having to sacrifice mice) and also provides the basis for experiments to

93

follow the fate of adipocyte stem cells as explained before. To monitor in vivo
luciferase activity, animals were anesthetized with isoflurane, and injected with
15 mg/ml D-Luciferin (Xenogen, Alameda, CA) i.p.

Luciferase activity was

imaged using the IVIS Lumina machine (Xenogen) and the data were analyzed
using the Living Image software (Xenogen)(Franke-Fayard et al., 2006).

Of

importance, the software integrates signal over surface area of tissue so
approximately the same amount of adipose tissue is assayed in comparisons of
fed, fasted and ob mice.
This data provided the basis for the characterization of a series of
promoter deletions to fine map the cis regulatory elements of the leptin gene, as
a starting point for identifying interacting trans-factors.
Ultraconserved sequences around leptin gene
As a general rule of thumb for studying promoters of genes, researchers
make use of comparative DNA sequence analysis to identify conserved
sequences in the vicinity of the gene of interest to guide the making of promoter
deletions. Leptin gene has evolved with emergence of vertebrates. However, its
function as a lipostat sensor seems to have evolved with endothermic animals,
especially mammals. For this reason, vicinity of leptin gene has been checked for
high conservation among mammals.
Fortunately, the chromosomal region in the vicinity of the ob gene has
been extensively sequenced in a number of organisms. Genomic sequences
around leptin gene from several mammalian animals were aligned by using
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VISTA program for finding conserved regions, which might be candidates for
possible transcription binding sites. Genomic sequences have been retrieved
from UCSB genome browser. This analysis identified 2 ultraconserved regions,
one being in the -17kb upstream of leptin, the other being in the first intron
(Figure 40).

Figure 40: Conservation of sequences around leptin gene
Data has been retrieved using UCSC genome browser. 0 indicates the TSS of leptin. Note the
high conservation between -17kb and +3kb.

-22-0 kb regulatory sequences carry fat specificity and fat sensing
Since, the 5’ upstream sequence of a gene is usually regarded as the
most critical region for transcriptional regulation, 22kb upstream region of the
leptin gene were used to make transgenic animals as the next step. Note that
this construct does not carry any introns, since the luciferase is inserted in the
first exon. -22-0kb transgenic animals, carrying 22kb upstream region, conferred
fat tissue specific expression and the expression is regulated by fasting and
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obesity (Figure 41). On the other hand; -762bp-0 transgenic animals, carrying
762 bp upstream sequence, showed no fat tissue specificity in all two founders,
both having ovary/testis specific luciferase expression (Figure 42). One issue
with the –22-0kb animals is that the quantity of luciferase expression was 50-100
times less compared to the transgenic lines where luciferase was inserted into
the translation start site, namely -160-18kb, -22-140kb and -22-18kb (Data not
shown). This low expression can be ameliorated by adding a chimeric intron;
however it might also suggest the existence of an enhancer region in the intron.
These data suggest that 22kb upstream sequence is enough to drive fatspecific expression and lipid sensing properties of leptin. Further, 762bp
promoter is not enough to drive fat-specific regulation of leptin.

Figure 41: Luciferase expression in -22kb-0 Luciferase animals
Expression of luciferase was assessed by in vivo imaging using an IVIS CCD camera.
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Figure 42: Luciferase expression in -762bp-0 Luciferase animals
Expression of luciferase in ovaries and testis was assessed by in vivo imaging using an IVIS CCD
camera. No expression was observed in the fat tissue

-17kb conserved region histones are hyperacetylated and hyper
monomethylated
Patterns of histone modifications influence transitions between chromatin
states and the regulation of transcriptional activity. Different histone marks have
been proposed to have different effects on transcriptional activity. Some of these
marks are enriched in enhancers, and some in promoters as some are
associated with active transcription whereas others are associated with
repression. There are many reports regarding the histone marks at distant
enhancers by several different groups. H3K4 methylation is often linked with
transcriptional activity in many contexts. Specifically, H3K4 trimethylation is
associated with promoter regions of almost all active genes (Choi and Engel,
1986b). Recently several groups also found associations between active
enhancer

regions

and

H3K4dimethylation

and/or

H3K4monomethylation

(Bernstein et al., 2006; Robertson et al., 2008; Roh et al., 2007). In addition,

97

there seems to be a direct correlation between active transcription and histone
acetylation (Ruthenburg et al., 2007).

In contrast, H3K27 trimethylation is

associated with promoters of inactive genes. In an earlier study, Litt et al.
performed a “chromosome walk” on DNA sequences for the beta globin gene,
testing previously known to be active or inactive regions, by performing Chip
assays using antibodies against H3K4 marks (Litt et al., 2001).
Since the elements conferring leptin regulation is thought to be between 22kb and -762 bp region, it was hypothesized that the only ultraconserved DNA
stretch in this region may be functionally important. For this reason, chromatin
immunoprecipitation analysis has been performed around the -17kb region.
Basically, fat tissue was fixed, lyzed and nuclei were isolated. Nuclei later were
lyzed and sonicated and immunoprecipitated with the corresponding antibodies.
H3K9Ac and H3K4monomethyl antibodies were used for immunprecipitation. For
analysis, sybr green real time PCR analysis was used. PCR fragments with 800
bp intervals were designed around -17kb region and input and IP samples were
analyzed by Real Time PCR. The results show that -17kb region was indeed
enriched for H3K9Ac and H3K4monomethyl marks (Figure 43). Both of these
marks before were shown to be enriched in enhancer regions using whole
genome CHIP studies.
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Figure 43: Chip analysis of -17kb conserved region

Figure 44: Deletion analysis of leptin-Luciferase BAC transgenic animals
Table shows the current state of the characterization of BAC transgenic constructs.
Fat specificity shows if the corressponding luciferase-BAC transgenic line recapitulates fatspecific expression of leptin.
Expression level shows the luciferase expression of the corresponding BAC transgenic animal.
“?” indicates that the work is in progress. “H” indicates high expression of luciferase as assessed
by in vivo imaging using IVIS CCD camera. “L” indicates low expression.
Fat sensing shows if luciferase expression in the animals recapitulate the lipid-sensing regulation
of leptin. “Y” indicates that the animals recapitulate the fat sensing property of leptin. This is
assessed by crossing the animals to obese (ob/ob) animals versus fasting the animals for 48
hours.
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Further deletion analysis of leptin promoter
As the next step, more deletion constructs were made to refine the region.
As shown in figure 44, deletions from -17kb down to -762bp constructs in the
context of +18kb downstream have been made, assuming that the element is
between -22kb to -762bp region. Surprisingly -762bp-18kb (also 762bp-8kb)
transgenic animals conferred fat tissue specific expression of luciferase.
Furthermore, this expression was at high levels. Note that only -762 bp region
alone was not enough to confer any fat-specific expression. These results
suggest that leptin regulation might be redundant or a complex regulation is
taking place which will be discussed in the final discussion section (Figure 44).
Search for trans-factors regulating leptin gene expression
One approach to find possible transfactors and mechanisms that regulate
leptin expression is by using microarray analysis. DNA microarray represents a
powerful tool in biomedical discoveries. Harnessing the potential of this
technology depends on the development and appropriate use of data mining and
statistical tools. Leptin is regulated differently in different metabolic states. This
range of regulation is extremely helpful for microarray analysis, since it will
restrict the number of hits to a minimum due to the availability of multiple
comparisons.
Leptin is adipocyte-specific such that when the adipose tissue is
dissociated by collagenase digestion, the pelleted stromavascular fraction does
not have any detectable leptin mRNA compared to adipocytes. The assumption
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would be that any factor that confers fat specificity should be enriched in
adipocytes. For this reason, a DNA chip analysis was performed to identify genes
that are enriched in the adipocyte fraction compared to stromavascular fractions.
Interestingly, only a handful transcription factors were enriched in adipocyte
fraction. These transcription factors include, CHREBP(MLXIPL), which is known
to be a glucose sensor transcription factor that is also expressed in several other
organs such as liver, (Dentin et al., 2005; Mason et al., 1998) PPARƔ/RXR,
which is thought to be the master regulator of adipogenesis, C/EBPα, a gene that
was shown to regulate adipogenesis and leptin expression in vitro, (Mason et al.,
1998) SREBP, a cholesterol sensing transcription factor (Kochan, 2003;
Stelmanska et al., 2005) and DBP, a zinc finger factor with relatively unknown
function (Mikhailov et al., 2008) (Figure 46).
Since -762bp-8kb region which includes 762 bp promoter and 8kb first
intron, confers high expression in adipose tissue, the conserved regions and
possible transcription factor binding sites were analyzed. Conserved region in
762 bp promoter contains a C/EBP binding site along with Cdx/USF binding
sites. Ultraconserved region in the first intron contains C/EBP binding sites along
with GATA binding sites, which were before shown to be important in
adipogenesis. These transcription binding sites might provide useful with regard
to their binding to the putative leptin regulatory elements (Figure 45).
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Discussion
The in vivo analysis of leptin regulation suggests that leptin regulation is
more complex than it was previously thought using in vitro systems (Chen et al.,
1999; Hollenberg et al., 1997; Mason et al., 1998). -762 bp promoter, which was
shown to contain elements for C/EBP factors, is not enough to confer leptin
regulation (Mason et al., 1998). The cis-elements possibly involve a fat-specific
regulatory domain along with an enhancer domain. The possible binding sites
found in 762 bp promoter and ultraconserved sequence in the intron for C/EBP
and GATA suggest that these transcription factors which were before shown to
be expressed in adipocytes might indeed have roles in regulating fat-specific
expression of leptin. However, the fact that these transcription factors are also
expressed in 3T3-L1 adipocytes, cannot explain why leptin is not expressed in
this system. It is likely that a novel combination of transcription factors are lacking
in 3T3-L1 adipogenesis. These issues will be discussed more thoroughly in the
final discussion chapter.
Dissecting cis-acting regulatory sequences using genomic clones and
reporter genes has been performed mostly in cultured cells and in vitro systems
rather than animals because transgenic methods are relatively inefficient, costly
and regulatory regions for proper expression in vivo usually lie large distances
from the targets and cannot be included in conventionl plasmids. A significant
advance came from the discovery of modification of bacterial artificial
chromosomes using BAC recombineering (Warming et al., 2005). This method
has been used by several groups to identify cis-acting regulatory sequences and
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locus control regions (Carvajal et al., 2001; Huang et al., 2000; Jamsai et al.,
2003; Kaelin et al., 2004; Lehoczky and Innis, 2008; Oginuma et al., 2008;
Smale, 2003; Yu et al., 1999). Dissection of cis-acting transcriptional regulatory
elements using reporter genes in BAC transgenic mice can provide insights into
eukaryotic gene regulation in vivo.
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Figure 45: Conserved sequences and transcription binding sites in -762bp-+8kb sequence

Figure 46: Transcription factors enriched in adipocytes compared to SVF fraction
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Chapter 7:
Practical Applications of Leptin-luciferase Animals
Introduction
Leptin-luciferase BAC transgenic mouse line expresses luciferase under
the control of leptin promoter elements, making it possible to assess the activity
of the leptin gene in vitro biochemically, and in vivo by imaging of luciferase
activity with a CCD camera (Figure 26-28) (Contag and Bachmann, 2002). Since
leptin level is highly correlated with adipose tissue mass,(Ahima and Flier, 2000;
Frederich et al., 1995; Jernas et al., 2006; Maffei et al., 1995a) the leptinluciferase animal model also provides a novel means for assessing adipose
tissue mass non-invasively in vivo. Possible applications for this line include the
delineation of the embryonic origins of adipose tissue, as discussed in the
previous chapters, and screens for modulators of adipose tissue mass. In
addition half-life of luciferase (~3 hours) enables to study relatively short changes
in gene expression (Leclerc et al., 2000). In this chapter, this strain was
employed to study the response of adipose tissue before and after either food
restriction or leptin treatment. These experiments enabled the identification of a
novel cellular program that allows the conversion of glycogen intermediates to
triglycerides in hypoleptinemic conditions.
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Results
Fasting and refeeding induce dynamic responses in leptin-luciferase
expression levels in adipocytes
The level of luciferase was monitored in animals during a three day fast
and after refeeding. These experiments were performed in the same animal over
time using the CCD camera. Luciferase activity fell gradually over the course of
the fast and by three days there was a ~6-8 fold lower level of luciferase activity
(Figure 47A). Luciferase activity returned to baseline by 6 hours after refeeding.
Because 6 hours is not enough time to regenerate the adipocyte population, this
extremely rapid recovery of the leptin-luciferase signal after refeeding suggested
the possibility that lipid depleted adipocytes persist in adipose tissue after fasting.
Consistent with this, histological analysis at the conclusion of the threeday fast showed smaller adipocytes with a markedly lower cellular lipid content
(Figure 47B). The identity of these cells as adipocytes was established by
immunohistochemical staining with an antibody to aP2, an adipocyte specific
marker (Figure 47B). However, note that there was residual lipid in some of the
adipocytes after the fast, evident by significant luciferase activity and thus sought
to identify conditions under which there was near complete depletion of cellular
lipid in adipocytes. This was accomplished by treating animals with leptin.
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Figure 47: Time course luciferase activity in leptin-luciferase animals upon
fasting/refeeding
(a) Time course luciferase activity in leptin-luciferase animals upon fasting and refeeding. The
level of luciferase in animals was monitored during a three day fast and after refeeding . The
data were collected for the same animal over time. (n=4) Luciferase activity fell gradually over
the course of the fast. After refeeding, luciferase activity returned to baseline by 6 hours. (Upper
panel) Representative time-course images of fasted and refed animals are shown. (Lower panel)
Quantitation of in vivo signals by Living Image 3.0 software. (mean +/-SEM). (b)Histological and
immunohistochemical analysis of adipose tissue of fasted mouse. H&E staining of wild-type (left)
and fasted (middle) animals for comparison. Note that nuclei are approximately the same size.
Immunohistochemical staining of the adipocyte specific protein, aP2, in fasted animals (right).
The fasted fat pad consisted almost entirely of adipocytes expressing high levels of aP2 protein.
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Figure 48 Body weight, food intake, serum leptin, serum insulin and serum glucose of
acutely leptin deficient mice
(A) Leptin treatment resulted in a rapid and sustained decrease in body mass relative to PBS
control animals (blue squares). When exogenous leptin was withdrawn (leptin withdrawal, Right),
free-fed animals (Leptin-FF, green circles) rapidly gained back lost weight while animals
maintained at normocaloric intake levels (Leptin-NC, red triangles) rebounded more slowly. (B)
Leptin treatment decreases food intake only while body mass is being lost after which time levels
return to normal. Following leptin withdrawal, hyperphagia ensued in leptin-FF animals, while it
was prevented in Leptin-NC mice in order to control for effects simply due to an increase in food
intake. (C) Serum leptin levels were 20 fold elevated during leptin treatment and dropped
precipitously following leptin withdrawal relative to PBS control animals (blue bars). In leptin-FF
mice (green bars), levels were low for two days (WD Day 1 and WD Day 2), while in leptin-NC
(red bars) mice, low serum leptin persisted for four days. Statistically significant differences are
noted (*, P < 0.05 vs. PBS; #, P < 0.06 vs. PBS; **, P < 0.005 vs. PBS). (D) Serum insulin levels
are 12 to 20 fold lower than PBS controls following 6 or 8 days of leptin treatment (*, P < 0.05 vs.
PBS; **, P < 0.005 vs. PBS). Following leptin withdrawal, insulin rose in Leptin-FF mice while
maintaining mice on normocaloric intake prevented any rise in serum insulin (†, P < 0.05 vs.
Leptin-FF). (E) Normal serum glucose levels were evident in all groups before and after leptin
withdrawal.
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Leptin treatment induces near complete delipidation of adipocytes,
conserving adipocyte specific protein expression
Mice were treated with high dose leptin via subcutaneous pump for 8
days. Leptin treatment led to a complete depletion of all visible body fat which
was associated with the complete absence of luciferase expression (Figure 49).
Histology of the adipose depot after 8 days of leptin showed a dense population
of cells with little or no detectable cellular lipid. However, these lipid-depleted
cells still showed high levels of the adipocyte-specific protein aP2 expression
suggesting that after leptin treatment the adipose tissue was populated by lipid
depleted adipocytes (Figure 49).
After eight days the leptin osmotic pumps were removed. Following
withdrawal of exogenous leptin, animals fed ad libitum became markedly
hyperphagic and body fat mass returned to pretreatment levels over the course
of four days (Figure 48). Luciferase levels were clearly detectable in animals
post leptin withdrawal after one day; and after 4 days the luciferase signal
returned to baseline levels (Figure 49).
The data from leptin treated animals were consistent with data from fasted
animals and suggested that under both conditions the adipose depot is
composed of lipid depleted adipocytes. The data further suggest that leptin
treatment leads to the complete depletion of cellular lipid providing a unique
opportunity to study the molecular programs that are responsible for the repletion
of cellular lipid.
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Figure 49: Leptin withdrawal experiment
(a) In vivo imaging of leptin-luciferase animals upon leptin withdrawal. PBS (n=6) or leptin at 2.5
µg/hour (n=5) was administered for 8 days by subcutaneous implanted osmotic pump. On day 8,
leptin or PBS treatment was withdrawn by removing pumps under inhaled anesthesia. Animals
were imaged before treatment, after 8 days of leptin treatment and daily for the 4 days following
removal of leptin pumps. Leptin treatment resulted in a rapid and sustained decrease in leptin
expression and fat depots relative to PBS control animals. Note that no significant luciferase
activity was detected after leptin treatment. After exogenous leptin was withdrawn, luciferase
activity in adipose tissues from free-fed animals returned to original levels in 4 days. (Upper
panel) Imaging results of representative animals form PBS and leptin treated groups are shown.
(Lower panel) Quantitation of in vivo signals by Living Image 3.0 software indicates a dramatic
suppression of luciferase by exogenous leptin treatment (mean +/-SEM). (b)Preservation of
adipocyte identity during chronic leptin treatment. Leptin treatment results in near complete
depletion of triglyceride droplets from white adipose tissue. White adipose tissue of mice treated
for 8 days with leptin consists of dense islands of cells as assessed by hematoxylin and eosin
staining (middle). Note for comparison that nuclei are the same size. Immunohistochemical
staining demonstrated high levels of the adipocyte specific protein aP2 in the cytoplasm of high
numbers of cells in de-lipidated white adipose tissue (right, brown, peroxidase positive material).
Fat pads of leptin treated animals consisted almost entirely of adipocytes expressing high levels
of aP2 protein, despite lack of preservation of typical adipocyte morphology.
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Recovery from Hypoleptinemia Increases Cellular Glycogen Prior to
the Reappearance of Cellular Lipid
In order to study the cellular programs activated when fat mass is
repleted, RNA was prepared from adipose tissue during leptin treatment and
after 1-4 days post leptin withdrawal for use with oligonucleotide microarrays to
follow the patterns of gene expression after leptin withdrawal. While preparing
the RNA from these samples, we noted the appearance of large amounts of a
white flocculent material after ethanol precipitation. This material had the gross
appearance of glycogen. To confirm this, tissue glycogen levels were checked
biochemically. On the first day post leptin withdrawal there was a massive
increase in glycogen content in the adipose depot with a total glycogen content of
1 % of the total wet weight of the tissue (Figure 50). Treatment of acutely leptindeficient white adipose tissue lysates with amyloglucosidase, an enzyme which
specifically hydrolyzes glycosidic bonds (Keppler, 1974) liberated a large amount
of soluble glucose, confirming the presence of high levels of glycogen. Periodic
acid-schiff (PAS) staining of tissue sections showed dense staining in cells
containing small lipid droplets confirming the presence of glycogen granules in
adipocytes (Figure 50). The PAS stained material was further confirmed to be
glycogen by pre-digesting tissue sections with α-amylase which eliminated PAS
positive granules. Intense staining was visualized in a similar pattern to that
shown previously for aP2 (Figure 50).
The total glycogen content decreased over the ensuing 3 days by which
time adipose tissue mass had returned to the same level as prior to treatment.
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Histological analysis over this period indicated enlarging adipocyte lipid droplets
in the same cells that showed PAS staining for glycogen (Figure 50).

Figure 50: Accumulation of white adipose tissue glycogen during acute leptin deficiency
(a) White adipose tissue glycogen content rose 30 to 60 fold in leptin withdrawal animals(green
and red bars) relative to PBS controls (blue bars) following withdrawal of exogenous leptin
treatment, as measured by glucose liberated by amyloglucosidase (*, P < 0.05 vs. PBS; #, P <
0.065 vs. PBS). This increase occurred in both free-fed animals (Leptin-FF, green bars) and
animals maintained at normocaloric intake levels (Leptin-NC, red bars), and increased glycogen
content persisted for 3 and 4 days in these groups, respectively. (b) Periodic acid-schiff (PAS)
staining of white adipose tissue on withdrawal day 1 and withdrawal day3. PAS staining on
withdrawal day 1 indicated large amounts of cytoplasmic glycogen content in leptin-FF and leptinNC tissue sections (black arrows). This contrasted sharply with control PBS treated white adipose
tissue. On withdrawal day 3, glycogen accumulation decreased in parallel to the accumulation of
lipid. (red arrows) a-Amylase pretreatment of tissue sections eliminated PAS positive granules in
adipocyte cytoplasm, indicating specificity of staining for glycogen.
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Figure 51: Pathway of acetyl-CoA and glycerol generating enzymes upregulated by acute
leptin deficiency.
Acute leptin deficiency induced the pathway of genes (blue ovals) necessary to synthesize
cytoplasmic acetyl-CoA and glycerol from simple sugar precursors. Fold change for each gene on
day 1 following leptin withdrawal is shown below each enzyme name for leptin-FF (left) and
leptin-NC (right) mice with the associated P value immediately below each fold change value.
Potential sources of carbon for acetate or glycerol synthesis are in blue text.
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The Transcriptional Program Associated with Recovery of Adipose
Tissue Mass
These data suggested that the repletion of cellular lipid content and
adipose tissue is achieved via a glycogen intermediate in lipid-depleted
adipocytes. To study this further, transcription profiles of adipose tissue were
generated by analyzing RNAs at 6 or 8 days of leptin treatment and 1, 2, 3, and 4
days after leptin withdrawal (Figure 47-48). To refine the analysis, RNA was
prepared both from hyperphagic animals fed ad libitum after leptin withdrawal, i.e
leptin-FF as well as from animals whose food intake was restricted to that which
the animals ate voluntarily prior to leptin withdrawal, i.e leptin-NC animals
(defined above). As an additional control, tissues from PBS treated animals were
analyzed both before (day 6) and after (day 1 post-withdrawal) removal of the
osmotic pumps. In all cases, RNA was labeled using biotin and hybridized to
Affymetrix 11K oligonucleotide microarrays.
Selection and k-means cluster analysis (Soukas et al., 2000) of 683 genes
changing significantly across experimental conditions identified 14 statistically
distinct patterns of gene expression. Analysis clusters induced specifically by
acute leptin deficiency revealed an enrichment of genes associated with gene
ontology (GO) terms related to carbohydrate metabolism (Figure 51).
Specifically, many genes induced in adipose tissue during weight gain play a role
in glucose uptake, glycolysis, and acetyl-CoA and glycerol synthesis. An acute
decrease in circulating leptin level induced nearly the entire complement of
genes necessary to increase simple sugar flux into the adipocyte, and
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subsequently convert these sugars into cytosolic acetyl-CoA and glycerol for denovo fatty acid, triglyceride, and cholesterol biosynthesis (Figure 51). Average
expression level for these mRNAs peaked on day 1 of acute leptin deficiency but
remained elevated for four days following cessation of leptin treatment.
Leptin withdrawal also induced the expression of genes required for the
storage of cytoplasmic triglycerides including genes involved in the synthesis of
glycerol such as glycerol-3-phosphate dehydrogenase mRNA (3 and 2.8 fold in
leptin-FF and leptin-NC mice, respectively). This enzyme catalyzes the
conversion of dihydroxyacetone phosphate, a glycolytic intermediate, into
glycerol-3-phosphate (or vice versa). Triglyceride storage is also augmented
during acute leptin deficiency by a 70% and 30% induction of glycerol-3phosphate acyltransferase (GPAT) in leptin-FF and leptin-NC animals,
respectively. GPAT catalyzes the esterification of glycerol-phosphate and fatty
acids for storage in adipose tissue.
Acute leptin deficiency specifically repressed four groups of genes that
were induced or unchanged during chronic leptin treatment. These genes
included both carnitine-palmitoyl transferase-I (CPT-I) and peroxisomal acyl-CoA
oxidase (ACO) both of which are required for fatty acid oxidation. CPT-I, which
enhances mitochondrial uptake of fatty acids for oxidation, is decreased in leptinFF and leptin-NC mice 3.0 and 1.9 fold, respectively. ACO, which catalyzes
enzymatic fatty acid breakdown, is 2.7 fold repressed in leptin-FF mice and 1.3
fold

repressed in

carboxykinase

leptin-NC mice. White

(PEPCK)

mRNA,

which
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adipose

would

phosphoenolpyruvate

detract

from

acetyl-CoA

accumulation, was repressed 36 and 2.4 fold in leptin-FF and leptin-NC animals,
respectively (Figure 51).
Leptin withdrawal did not regulate the mRNA of genes involved in
glycogen synthesis or glycogenolysis suggesting that the induction of glycogen
synthesis is not regulated at the level of transcription (Figure 51). As discussed
below, these data suggest that the genes required for glycogen synthesis
continue to be expressed in adipocytes in the setting of weight loss and thus
allow the accumulation of glycogen when food is consumed. Lipid synthesis
genes are repressed after a fast and this glycogen then serves as substrate for
the biosynthesis of triglyceride when the genes required for lipid synthesis are
induced.
Discussion
The cellular and molecular programs responsible for the repletion of
adipose tissue mass after weight loss has not been fully elucidated. In this
chapter, this issue was addressed using molecular genetics, physiologic and
computational tools and show that weight loss after food restriction results in the
partial loss of adipose tissue lipid while leptin treatment results in the persistence
of adipocytes that are nearly completely depleted of their cellular lipid. It was
further shown that the restoration of adipose mass acutely after re-feeding is
associated with the production of massive glycogen deposition that temporally
precedes the recovery of adipose tissue mass. Finally, it was shown that acute
hypoleptinemia activates a novel program of gene expression with the induction
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of gene products that convert glucose and other simple sugars into glycerol and
acetyl-CoA for triglyceride synthesis.
Leptin expression is markedly reduced after a three day fast and its level
of expression is restored nearly to baseline levels within 6 hours after refeeding.
This rapid repletion of leptin expression is too rapid to be consistent with the
possibility that there is apoptosis of adipose tissue followed by de-novo
adipogenesis. Rather these data suggested that fat loss after food restriction
results the depletion of lipid within adipocytes. This conclusion is supported by
data from immunohistochemical staining of adipose tissue with an antibody to
aP2, a fat specific gene,(Hunt et al., 1986) which is still expressed at high levels
in adipose tissue after a fast, at a time when there are markedly reduced
amounts of lipid. Eight days of leptin treatment caused an even more dramatic
reduction of adiposity and histological analysis of adipose tissue of leptin-treated
animals demonstrated dense nests of aP2 expressing cells that were largely
devoid of lipid. Thus, the rapid restoration of fat mass following acute leptin
deficiency does not appear to require new fat cell production. Several additional
lines of evidence support this conclusion. First, mitoses were not visible in tissue
sections from adipose tissue after leptin withdrawal during times when adipose
mass is being rapidly repleted. Second, as assessed using the data from the
transcriptional profiles, genes known to induce terminal differentiation of
adipocytes or that are involved in the clonal expansion phases of adipogenesis in
vitro (Gutman and Shafrir, 1964) remained unchanged or decreased in
abundance during acute leptin deficiency. In addition, previous studies have
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reported that adipose tissue from animals treated with leptin contains the same
DNA content as control samples (Zhou et al., 1999). Therefore, it was concluded
that the restoration of fat mass is the result of the activation of a program of lipid
re-accumulation in lipid-depleted adipocytes and does not appear to be
associated with de-novo adipogenesis.
The re-accumulation of fat mass following weight loss is the result of the
activation of a novel gene expression program that is activated by acute
hypoleptinemia. The initial phase of this cellular program is marked by an
increase in adipocyte glycogen content. The glycogen content of white adipose
tissue is normally exceedingly low (Cahill et al., 1959) and previous studies have
shown that fasting reduces glycogen levels even further while subsequent
refeeding transiently increases adipose tissue glycogen content (Gutman and
Shafrir, 1964; Rose and Shapiro, 1955; Tuerkischer and Wertheimer, 1942). The
stimulus for this response was not previously known. This data indicates that low
leptin levels provide this stimulus, such as those present with refeeding after a
period of food restriction or after leptin withdrawal. Furthermore, the studies of
animals experiencing leptin withdrawal in the context of restrained food intake
(Leptin-NC animals) further indicated that the observed increase in glycogen
synthesis in white adipose tissue after refeeding was not the result of
hyperinsulinemia (Kaslow and Mayer, 1979).
The increased pool of glycogen in white adipose tissue during fat
regeneration appears to provide the substrate for expansion of adipose
triglyceride mass. This conclusion is consistent with previous findings showing
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that adipose triglyceride stores are primarily synthesized within adipose tissue
and rather than being imported into fat cells after being synthesized elsewhere
(Rose and Shapiro, 1955). Glycogen-containing adipose tissue from animals
refed after a 48 hour fast was previously shown to have a respiratory quotient of
greater than 1.0 indicative of a high rate of glucose metabolism and not fatty
acids (Tuerkischer and Wertheimer, 1942; Wertheimer, 1945). In re-fed animals,
glycogen disappears from adipose tissue at the same time as fatty acid synthesis
is at its maximum and PAS positive material and lipid droplets can be easily seen
in the same cells during the recovery from weight loss (Rose and Shapiro, 1955).
Finally, glycogen is an efficient precursor of both components of adipose tissue
triglycerides, the fatty acid and glycerol moieties (Gutman and Shafrir, 1964). In
aggregate, these data suggest that the re-accumulation of fat mass following
withdrawal of leptin treatment or refeeding following a fast involves 1) the
increased glycogen synthesis which is likely to be substrate driven as mRNAs for
the genes involved in glycogen synthesis and breakdown do not fall during leptin
treatment or subsequent withdrawal, and 2) transcriptional induction of genes
required for lipid biosynthesis from monosaccharides.
Lipid stores in the adipocytes may arise from two major routes: de novo
lipogenesis from non-lipid precursors or uptake of fatty acids from plasma. In this
study, it is suggested that lipid repletion, at least following leptin treatment, may
be through a de novo lipogenic pathway involving a glycogen intermediate and
upregulation of transcriptional pathways. Adipose tissue, liver and mammary
glands (lactation) were before shown to be sites for de novo lipogenesis in
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mammals (Blouin et al., 2009; Lafontan, 2008). De novo lipogenesis has been
found to be active when small animals are fed on carbohydrate rich and low fat
diet (Blouin et al., 2009; Lafontan, 2008).

Another major route for triglyceride

deposition in adipose tissue is through the uptake of pre-existing fatty acids from
circulating triglycerides in form of chylomicrons/VLDL particles. It is still
controversial which of the lipogenic mechanisms is the major pathway for
adipose tissue lipid accumulation. It is possible that both pathways take place to
certain extents in different metabolic conditions. Note, it is also suggested by
several studies that the contribution of adipose tissue to the whole body
lipogenesis is relatively lower in humans. A comparison of lipogenesis in the
adipose tissue of humans confirmed that the capacity of lipogenic pathways of
adipose tissue is less in humans, possibly due to the lower abundance of the
transcription factors controlling the lipogenic pathways, namely SREBP-1 and
CHREBP (Letexier et al., 2003).
The failure of the mRNAs involved in glycogen metabolism to change after
fasting or leptin treatment is in contrast to the enzymes of glycolysis and the
enzymatic cascade necessary to generate acetyl-CoA from simple sugars, which
are clearly induced under these conditions. In previous studies these genes have
been reported to be regulated predominantly by post-transcriptional mechanisms
(Daran-Lapujade et al., 2004; Daran-Lapujade et al., 2007). Thus, the response
to leptin withdrawal or refeeding is not simply an induction of the same genes
repressed during leptin treatment and instead constitutes a novel program for
adipocyte gene expression. The transcriptional mechanism responsible for the
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upregulation of this functionally linked group of genes is not known and future
studies of the factors that regulate this program may provide new avenues for
limiting lipid re-accumulation in adipose tissue after weight loss and possibly
treating obesity.
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CHAPTER 8:
Conclusion
Summary of findings

Adipose biology field has long been driven by the in vitro models due to
the ease and availability of the cell lines that were discovered by Green and
colleagues. There is now evidence that the in vitro adipogenic processes do in
fact reflect in vivo events only partially. This urges the need to study adipocytes
in vivo. Major problems to study adipogenic processes in vivo are lack of
markers, poorly characterized in vivo animal models and unknown identity of the
adipogenic cell types. The development of new markers and characterization
studies on the adipocyte development in vivo will help to solve these problems.

The primary goal of this thesis has been to characterize the molecular and
cellular events in white adipose tissue in vivo. Firstly, an early transcriptional
network has been discovered including KLF4 and Krox20 as essential early
regulators of adipogenesis. Klf4 is expressed in 3T3-L1 cells within 30 min after
exposure to a standard adipogenic cocktail of insulin, glucocorticoids, and IBMX.
Knockdown of KLF4 inhibits adipogenesis and downregulates C/EBPβ levels.
KLF4 binds directly to the C/EBPβ (C/EBPβ) promoter as shown by chromatin
immunoprecipitation

and

gel

shift

assays

and,

together

with

Krox20,

cooperatively transactivates a C/EBPβ reporter. C/EBPβ knockdown increases
levels of KLF4 and Krox20, suggesting that C/EBPβ normally suppresses Krox20
and KLF4 expression via a tightly controlled negative feedback loop. KLF4 is
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specifically induced in response to cAMP, which by itself can partially activate
adipogenesis. These data suggest that KLF4 functions as an immediate early
regulator of adipogenesis to induce C/EBPβ.
Secondly, we characterized an early adipocyte progenitor cell population
which can reconstitute functional adipose in lipodystrophic animals. Use and
characterization of lipodystrophic animals was crucial for this result, because
transplantation studies using wild type animals do not result in any new functional
adipocytes, which is probably due to the quiescent state of the wild type adipose
as assessed by many other studies. A-ZIP lipodystrophic animals, however, were
found to be hyperadipogenic- as evaluated by the upregulation of early
transcription factors, KLF4, Krox20 and Pref1 that were previously identified and
hyperproliferative- as determined by BrdU incorporation studies. One other
model that helped the identification of adipocyte progenitor cells was leptinluciferase

BAC

transgenic

animals.

Leptin-luciferase

transgenic

mouse

expresses the luciferase reporter gene under the control of leptin regulatory
sequences, which allows noninvasive imaging of the leptin expression of
adipocytes in vivo. Cell sorting studies identified a subpopulation of early
adipocyte progenitor cells (Lin :CD29+:CD34+:Sca-1+:CD24+) resident in adult
WAT. When injected into the residual fat pads of A-Zip lipodystrophic mice, these
cells, sorted from leptin-luciferase animals, reconstituted a normal WAT depot
and rescued the diabetic phenotype that developed in these animals. The
development of adipose was determined using a CCD camera, since luciferase is
expressed only in mature adipocytes. This study provides the identification of an
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undifferentiated adipocyte precursor subpopulation resident within the adipose
tissue stroma that is capable of proliferating and differentiating into an adipose
depot in vivo.

Adipocyte

differentiation

possibly

is

most

active

in

the

embryonic/postembryonic stages of life, and adipocytes increase their size
(hypertrophy) greatly as soon as energy intake starts. However, there is no
descriptive study on adipose tissue development in rodents up to this date. This
led us to characterize mouse adipose tissue development. One caveat to study
adipose tissue development is that the adipocyte markers are thought to be
expressed after the accumulation of lipids according to in vitro data. However, it
is very likely that the adipocyte character and commitment occurs before the
accumulation of lipids. In this regard, lipid itself cannot be used to localize where
adipose tissue develops. Leptin-luciferase animals proved to be useful in this
regard. Even though luciferase expression was extremely low in these animals, it
was still detectable, making it possible to dissect and study the developing fat.
These studies showed that fat starts to accumulate after birth. More interestingly,
many of the adipocyte transcription factors/markers such as ap2, adipsin,
adiponectin, PPARƔ and C/EBPα that were thought to be expressed after fat
accumulation were actually found to be expressed high levels much earlier than
the accumulation of fat. This result was contradictory to 3T3-L1 studies, where
these genes are expressed after accumulation of lipid.

It implies that

adipogenesis in vitro does not exactly reflect the in vivo processes. This result in
a way shows the need for the field to move to in vivo systems.
124

As explained above, in vivo and in vitro adipogenic processes are
probably different. One other example to this phenomenon is the expression of
leptin gene. Leptin expression is ~100 times lower in in vitro differentiated
adipocyte cell lines compared to tissue levels (Hwang et al., 1997; Mandrup and
Lane, 1997; Mandrup et al., 1997a). Surprisingly, these adipocyte cell lines
abundantly express the master regulator PPARƔ, C/EBPs and their targets
(Hwang et al., 1997). This supports that the adipocyte-specific expression of
leptin is controlled by a different transcriptional mechanism than the conventional
adipocyte regulators. Studying leptin gene expression will give more insights
about adipocyte specific transcriptional networks. Moreover, leptin is secreted in
proportion to adipose tissue mass and in turn regulates food intake and energy
expenditure. Adipocytes secrete leptin in proportion to their size meaning that as
they accumulate more lipids, they secrete more leptin. This suggests the
possibility that cellular lipid content is sensed and that a fuller understanding of
the mechanisms controlling leptin gene expression could also lead to the
delineation of a lipid sensing mechanism in fat cells and possibly other cell types.
To discover this mechanism, we searched for the region in the leptin gene
promoter that controls the quantitative expression of the leptin gene; ie the
elements that confer increased leptin expression with obesity and decreased
expression after weight loss. Since leptin is expressed at much higher levels in
fat tissue in vivo than in vitro where it is not regulated in proportion to cellular lipid
content, these studies require that gene expression be monitored in vivo. We
thus generated a deletion series of BAC transgenic mouse lines that express
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luciferase under the control of overlapping leptin regulatory sequences. We
already have evidence that the cis element that confers qualitative and
quantitative control of the leptin gene is located between – 762bp and +8kb
relative to the transcription start site. This result suggests that leptin expression is
more complex than it was thought before.
As explained above, leptin mRNA levels are highly correlated with adipose
tissue mass, and leptin expression can thus be used as a surrogate for changes
in the amount of adipose tissue. Since luciferase is expressed by leptin
regulatory sequences in leptin-luciferase animals, which allows noninvasive
imaging of the leptin expression of mice in vivo, luciferase signal can be used to
track the lipid accumulation. Here leptin-luciferase mice were used to show that
weight loss induced by fasting or leptin treatment results in the retention of lipiddepleted adipocytes in adipose depots. To further study the cellular response to
weight regain after leptin treatment, a leptin withdrawal protocol was used to
induce a state of acute leptin deficiency in wild type mice. Acute leptin deficiency
led to the transient deposition of large amounts of glycogen within pre-existing,
lipid-depleted adipocytes. This was followed by rapid reaccumulation of lipid.
Transcriptional profiling revealed that this cellular response was associated with
induction of mRNAs for the entire pathway of enzymes necessary to convert
glucose into acetyl-CoA and glycerol, key substrates for the synthesis of
triglycerides.
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Future Directions and Concluding Remarks
The advent of DNA chip technology made it possible to analyze a plethora
of genes across different experimental conditions or follow gene expression
patterns through a time course. In this thesis, KLF4 and Krox20 were discovered
through a comparison between in vitro differentiated adipocytes versus in vivo
adipose tissue. The fact that there are earlier factors in 3T3-L1 differentiation
suggests that there may actually be more genes upregulated very early in
adipogenesis. These earlier genes may be discovered by an earlier time course
microarray analysis of 3T3-L1 differentiation. Identification of these factors may
give rise to broader analysis of early regulation of adipogenesis.
One caveat of studying earlier factors in adipogenesis is that the role of
several genes expressed early during development such as Krox20, KLF4 and
C/EBPβ cannot be studied in fat specific knockout mice because ap2-cre and
other drivers such adiponectin are expressed late in the course of differentiation
and would thus knock out these early genes at a point in time after their
expression is required. Furthermore, often times germ line and adipocyte specific
knockouts are uninterpretable when adipocyte genes are expressed in other
tissues in adults or during development. For this reason, either earlier markers
should be identified or another technique should be devised. Identification of
earlier markers is relatively difficult, because many genes that have roles in
differentiation of adipogenesis do also have roles in other differentiation
processes. To address this, an ES complementation approach can be
developed. This approach depends on the ability of ES cells to reconstitute the
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germ line when injected into blastocysts A/ZIP transgenic animals. Since A/ZIP
lipodystrophic animals do not have any fat tissue, all the fat in the chimeric
animals comes from ES cells. This approach can be employed to study the role
of specific genes during adipocyte development or on adipocyte function. For
example, the function of adipose genes by introducing siRNA plasmids to knockdown the expression of specific genes into ES cells can be used to validate the
role of three major early genes described above C/EBPβ, Krox20 and Klf4.
Preliminary experiments demonstrated that microinjection of wild-type embryonic
stem (ES) cells into lipodystrophic blastocysts produces chimeras that are
positive for the A/ZIP transgene but which have a normal adipose tissue mass
and normal blood glucose.

This is demonstrated directly by the fact that in

adipose tissue from these chimaeras, all of the adipocytes express YFP while in
other tissues there is a variable contribution from the ES cells such that fat tissue
is 100% YFP positive while liver and other tissues are not. Since the original
lipodystrophic background cells are incapable of making ES cells due to the
expression of dominant negative transcription factor against B-ZIPs, this shows
that all of the adipocytes are derived from the wild type ES cells.

These

preliminary results indicate that indeed an ES cell complementation strategy may
provide the tool to study adipogenesis in vivo.
Adipocyte progenitor cells can also be useful to study adipocyte
development in vivo. Since it was shown that CD24+CD34+ cell population can
differentiate into adipocytes in vivo, these cells can now be modified by
lentiviruses carrying siRNA/plasmids and transplanted into A/ZIP fat pads. This
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system will be extremely fast and cost–effective. It should be noted that it is still
not known how many different cell populations or differentiation stages there are
in adipogenesis. It is possible that adipocyte differentiation occurs through
different stages as it is for hematopoiesis. It is also not known if there are several
different cell types for forming different adipocytes such as the ones in
subcutaneous/ visceral or bone marrow adipocytes. Heterogeneity in adipose
tissue is an area that is poorly studied. It can be speculated that there can even
be different progenitor cells for different adipose types. If this is true, it is possible
to find different progenitors using same scheme but different cell sorting markers.
Leptin gene expression studies in this thesis sets up a starting point for
further studies. Up to this date, sequences regulating fat specificity and high
expression were confined between -762bp and +8kb, which spans the first intron.
Surprisingly, 762bp upstream sequence itself is not enough to confer fat
specificity and 22kb upstream sequence is enough to confer fat specificity. This
result suggests a redundancy for leptin expression. It is also possible that 762 bp
fragment is enough to confer fat specificity but is only effective with the enhancer
from either upstream or downstream. In either case, these studies will help for
further studies to identify the cis-elements that regulate leptin.Once the promoter
region(s) is localized to less than 1kB region, gel shift experiments can be
performed with nested ~ 50-100 bp fragments across the region using nuclear
extracts from ob, fed and fasted adipose tissue. With this information in hand, it
is straightforward to perform DNAse foot printing to map the precise binding site.
This sequence can then be used as an affinity probe to facilitate the biochemical
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purification of the differentially expressed transcription factor.

This could

potentially allow working back to a putative lipid sensing mechanism.
One other approach to find possible trans factors and mechanisms that
regulate leptin expression is by using microarray analysis. Leptin expression is
upregulated in obese/high fat fed animals and downregulated in fasted animals.
Furthermore, leptin is adipocyte-specific such that when the adipose tissue is
dissociated by collagenase digestion, the pelleted stromavascular fraction does
not have any detectable leptin mRNA compared to adipocytes. In addition, leptin
treatment of obese animals causes a time-dependent decrease in leptin gene
expression. During development, leptin is reported to be upregulated postnatal
day 8-10 -also known as the leptin surge (Ahima and Flier, 2000). In addition,
time course microarray analysis of adipose tissue development show that leptin
expression increase as lipid accumulates after P0. All these different conditions
can provide as tools to find transcription factors that correlate with leptin gene
expression.
The identification of molecular and cellular pathways regulating adipocyte
development and regulation in vivo will have implications for basic and clinical
understanding of obesity. Furthermore, the availability of systems such as the
leptin-luciferase mice and hyperadipogenic A-Zip lipodystrophic animals will help
to identify new cell populations and give the way to characterize in vivo
adipogenesis. Overall, these approaches will provide a means to study the
potential of cells from various sources to form WAT and creates new possibilities
for the determination of the roles that individual factors play in the control and
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maintenance of WAT mass in vivo in a variety of nutritional states, including
obesity.
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